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CHAPTER I 
GENERAL INTRODUCTION 

GENERAL INTRODUCTION 
1 THE HEPATITIS В VIRUS 
1.1 Introduction 
The hepatitis В virus infection represents a major public health 
problem. It has been estimated that more than 2.10 people 
worldwide are carrying a pool of the infectious virus, which is 
potent enough to cause either horizontal or perinatal vertical 
transmission (117). The virus induces a variety of clinical 
manifestations, ranging from an absence of clinical symptoms, to 
acute and chronic hepatitis and liver cirrhosis, and to an 
association with hepatocellular carcinoma in 10-15% of the 
persistent carriers (63). Horizontal transmission occurs by 
apparent routes (through transfusion of blood or blood products and 
through needles) and unapparent ones, particularly between sexual 
partners. The important risk groups are hemophyliacs or other 
repeatedly transfused individuals, parenteral drug abusers, male 
homosexuals with varying partners, people living in endemic areas 
(such as China, South-tast Asia and subsaharan Africa, where 5-15% 
of the population is a hepatitis В virus carrier, 27,40) and to a 
lesser extent health care personnel such as surgeons, dentists and 
laboratory personnel. 
The hepatitis В virus (HBV) is a member of a small family of so-
called hepadna viruses (=hepatotrophic DNA viruses, 97) with many 
unique and unusual properties that distinguish it from any other 
known class of DNA containing viruses (119). Other members of the 
family are the ground squirrel hepatitis virus (GSHV, 68), the duck 
hepatitis virus (DHV, 69) and the woodchuck hepatitis virus (WHV, 
120). 
The HBV particle (also called Dane particle, 28) has a spherical 
shape and a diameter of about 42 run with a protein, lipid ana 
carbohydrate containing, 7 nm thick outer envelope (HBsAg) and a 27 
run hexagonal inner core or nucleocapsid (HBcAg). HBsAg may also be 
found as non-infectious aggregates with spherical or filamentous 
shapes of 16 to 25 nm (3). Calculations have been made that the 
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serum ot patients can contdin 10 НВьАд containing particles per 
If 7 
ml, ol which 10 have the structure of Dane particles and 10 
to 10 are really infectious (122). Besides HBcAg the 
nucleocapsid also contains a cryptic form of hepatitis "e" antigen 
(HBeAg, 12ÍJ), several enzymes among which a DNA polymerase (54) and 
a protein kinase (2). In addition there is a polypeptide which is 
covalently bound to the viral DNA (41). 
1.2 The structure of HBV DNA and its products (see figure 1) 
Knowledge about HBV DNA and its products is not only derived from 
studies on HBV but has also been extracted from studies on other 
hepadna viruses (40,119). The viral DNA is a partially single-
stranded molecule with a long minus strand of about 3.2 kilobases 
(kB), except for a short gap (25,30,114). A protein is covalently 
bound to the 5' end of the minus strand (41). The plus strand 
begins at a unique place and is extended by the endogenous 
polymerase to a variable but average length of 1100 bases. The 
viral DNA is held together only by a 200 bases overlap between the 
5' minus strand and the plus strand (103). 
HBV DNA contains four open reading frames clustered in the 3.2 kB 
minus strand. No significant reading frame exists in the plus 
strand (119). The open reading frame for the S gene contains three 
in phase ATG sites (start codons for protein synthesis). The most 
downstream initiation site is generating the 226 amino acids (AA) 
long ma]or HBsAg protein (25 kilodalton (kD), also called P25 and 
GP2b in the glycosilated version). The ATG site, 165 bases 
upstream, initiates the production of the major protein extended 
with a 55 AA sequence known as pre-S2, thus yielding the HBsAg 
middle protein (P31-33, GP36). The P31 protein has the ability to 
bina polymerized human serum albumin and this binding appears to be 
dependent on the pre-S2 extension. The binding is presumed to have 
a function in virus entry into the host cell (40,132). Another ATG 
codon on the S gene, again 357 bases further upstream, codes for 
another 119-128 AA extension known as the pre-Sl determinant, thus 
coding for the HBsAg large protein (42-45 kD). This protein 
therefore contains the S, pre-S2 and pre-Sl antigenic determinants 
(43,134,143). The pre-Sl peptide may have a receptor function too 
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Fig.1 Physical and genetic map of HBV DNA. In the circular map 
of HBV DNA, the broken line in the short plus DNA strand repre-
sents the variable lengths in which the plus strand may occur 
in various molecules, and the corresponding region of the long 
minus strand is that which may be single-stranded in different 
molecules. The restriction sites and locations of the nick in 
the minus strand and the location of the single stranded region 
are as reported by Siddiqui et al.(114) and Tiollais et al. 
(134) and the open reading frames (large arrows) are according 
to Valenzuela et al.(141) and Tiollais et al.(134). The RNA 
transcripts are as mapped by Saito et al.(101) and Enders et 
al.(36). In the HBV genome represented as a linear sequence, 
the transcriptional enhancer is that reported by Shaul et 
al. (112). 
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(79). Doth pre-Sl and pre-S2 antigens may also have an important 
role in virus assembly (90). In chronic carriers, pre-Sl can be 
found in Dane particles as well as in filamentous HBsAg particles. 
The presence of pre-Sl in serum seems to have a good correlation 
with active virus replication (72,129,130). The pre-S2 antigen has 
an immunodominant epitope. Antibodies to pre-S2 may reveal an early 
marker for recovery after HBV infection (19). The pre-S2 antigen 
might therefore be of additional value in vaccines (51,76). 
Furthermore, detection of pre-Sl and anti-pre-S2 may therefore have 
a diagnostic value for the staging of HBV infection (60). 
The second open reading frame, the С gene, has two ATG sites, one 
initiating the generation of the capsid HBcAg (P19), and the other 
an upstream site initiating the precore polypeptide. The complex of 
both forms a 22 kD protein. The precore antigen is strongly 
hydrophobic and may target the core antigen to cellular membranes 
(probably the endoplasmic reticulum) during viral packaging 
(69,140). HBeAg (15.5 kD) is probably derived from HBcAg by 
proteolytic cleavage of HBcAg containing the pre-C sequence 
(66,65). 
Overlapping both former reading frames and covering 60% of the 
viral genome, but using another, not in-phase, nucleotide register 
is the A or Ρ gene, probably encoding the viral polymerase with a 
molecular weight of over 90 kD (119). 
The fourth open reading frame (B or X) is sufficient to encode a 
protein of some 135 AA. However, there is still hardly any evidence 
at present for the existence of such a protein associated with HBV 
infection. The putative protein can generate antibodies (74,90,95) 
and may have an association with HBcAg (38) and a function in the 
development of HCC (74,98). 
2 MECHANISMS OF VIRAL REPLICATION 
The mechanism that is used by HBV to gain entry into the host cell 
is not well understood. However it is likely that HBV, like other 
viruses, employs specific receptor molecules for adsorption 
followed by penetration into the cytoplasm through the membrane 
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fusion of viral and cellular plasma membr<mes or endocytosis (40). 
A receptor for polymerized human serum albumin (pHSA) has been 
found both on the pre-S2 region of Dane particles and on liver cell 
plasma membranes. It has been suggested that pHSA is the linker 
between HBV and hepatocytes and is essential for virus attachment 
and adsorption (42,65,86,102,129,132). Other findings, however, 
indicate a specific affinity of 125I labelled HBsAg (P25) for 
human hepatocytes (64). Furthermore, evidence has been obtained for 
a specific ligand in the pre-Sl region (79) and the pHSA system is 
regarded as non specific and non functional (50,92). 
Entry of HBV into the cell, either by fusion of the viral and 
cellular plasma membranes or by uncoating of the virus by lysosomal 
enzymes, will result in the release of viral nucleoproteins. The 
viral DMA is then converted in the cell nucleus to a double-
stranded closed circular form which will function as a template for 
transcription (70,73,98). 
Three types of mRNAs have been demonstrated so far as being 
products of the viral genome (see figure 1): a polyA+ RNA of 2.3 
kB long and a polyA+ RNA of 3.5 kB long (20,22,36,118,146) and a 
recently discovered short mRNA of 0.7 kB (101). The 2.3 KB mRNA 
codes for the major HBsAg, with or without the pre-S2 region. The 
0.7 kB mRNA probably codes for the putative X protein and the 3.5 
kB mRNA (longer than the total genome 1) codes for the core or 
precore site whilst also functioning as the pregenomic viral RNA 
(37,119). 
The pregenomic RNA and the newly synthesized viral polymerase 
(which has a striking resemblance with retroviral reverse 
transcriptase, 98,121,135), HBcAg and other viral core proteins are 
packed into immature cores in the cytoplasm. The plus strand RNA is 
reverse transcnpted into minus strand DNA with simultaneous 
degradation of the RNA template as DNA synthesis proceeds (40). 
Once the the minus strand is complete the viral DNA plus strand is 
synthesized using the minus strand as a template. The core 
particles are coated by HBsAg and cell membrane lipid containing 
envelopes, and exported from the cell (48,53). The plus strand is 
not necessarily completely finished before coating and release take 
place. In infectious sera incomplete plus strands or even DNA-RNA 
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hybrids can be found. 
Although the different steps of viral replication seem to take 
place predominantly in the cytoplasm, the exact locality of these 
processes has not been defined (8,9,87,121). Furthermore, the route 
of virion assembly and the time required for the production of the 
virus and viral components are still not well determined. HBsAg 
polypeptides appear to self assemble and form 22 nm spheres 
(55,141) or may interact with the endoplasmic reticulum (ER) 
(Ь9,140) in the formation of glycolipid containing HBsAg particles 
and the envelope of the Dane particle (40). Immuno ultrastructural 
studies of a hepatic homograft that became infected after 
transplantation revealed amorphous HBcAg in the cytoplasm on the 
12th day after infection, probably produced by free and membrane 
bound polysomes. After migration into the nucleus, HBcAg is 
assembled on the 22nd day into core particles (53,145). Gerber and 
Thung (40) suggested that the core particles migrate from the 
nucleus through the nuclear pores into the cytoplasm and protrude 
into the ER cisternae and, possibly via the pre-C sequences, 
invaginate the HBsAg containing ER membranes that will coat the 
core particles. Thus complete virions may be formed by budding into 
the ER cisternae. Having been transported to the Golgi apparatus, 
and processed there, the virions might be secreted by exocytosis or 
reversed pinocytosis. 
Although this working hypothesis for viral replication is 
attractive, many observations have been made in patient material on 
ultrastructural and immune histological levels that cannot be 
explained by this theory (39). 
3 CLINICAL COURSE AFTER HBV INFECTION 
Various courses of liver disease may develop after HBV infection. 
It may result in acute icteric hepatitis with a small percentage of 
cases leading to death, non icteric hepatitis or no hepatitis at 
all. In any of these cases the virus can be cleared, leading to 
recovery, or can persist, leading to the development of chronic 
HBV. Chronic HBV carriers may be asymptomatic, or develop chronic 
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persistent or chronic active hepatitis, with a mild, moderate or 
severe clinical manifestation. Chronic hepatitis may result in 
cirrhosis and/or primary hepatocellular carcinoma (31). 
3.1 Serology in acute hepatitis В 
During the course of acute hepatitis HBsAg appears in the serum 
before the onset of clinical disease. It then rises to peak titers 
at or around the time of the onset of symptoms (see figure 2A). 
HBsAg usually persists throughout the symptomatic phase of illness 
ana becomes undetectable during recovery. After HBsAg has 
disappeared, the antibody to HBsAg (anti-HBs) arises, usually after 
a short "window" period during which neither HBsAg nor anti-HBs is 
detectable (104). The non appearance of anti-Hbs (in about 10% of 
the patients) may indicate the development of chronic hepatitis. 
Antibody to HBcAg (anti-HBc) arises however in all patients with 
HBV infection and appears at or around the time of the onset of 
symptoms. Anti-HBc is the only serological marker that is always 
present after HBV infection and is therefore particularly 
invaluable in sero-epidemiologic surveys (104). HBcAg is not 
detectable in serum at any stage. HBeAg, apparently derived from 
processed HBcAg, becomes detectable however in the serum of 
patients with acute hepatitis at the same time as HBsAg appears. 
Serum HBV DNA (32) and DMA polymerase usually accompany HBeAg. 
these markers have a good correlation with high titers of 
infectious particles in the serum and with active virus replication 
and are cleared before HBsAg. Of these three markers HBV DNA seems 
to be the most reliable and sensitive for the detection of 
infectious particles (12,106). Most patients become HBeAg negative 
and anti-HBe positive at or around the time of peak serum liver 
enzymes and maximum disease activity. Seroconversion in acute 
hepatitis from HBeAg to anti-HBe is therefore a good indication for 
the clearance of viral particles and the cessation of disease 
activity. 
3.2 Serology in chronic hepatitis В 
Persons who become chronic HBsAg carriers frequently persist in 
being HBeAg positive (59) and maintain high levels of HBV DNA, DNAp 
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Fig.2 The typical serological course of acute (A) and chronic 
(B5 type В hepatitis. HBsAg, hepatitis В surface antigen; Anti-
HBs, antibody to HBsAg; HBeAg, hepatitis В e antigen; Anti-HBe, 
antibody to HBeAg; Anti-HBc, antibody to hepatitis В core 
antigen; DNA-p, DNA-polymerase; ALT, alanine aminotransferase; 
HBV DNA, hepatitis В virus DNA. 
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and HBsAg (see figure ¿B). Positivity of HBsAg for at least six 
months defines a chronicity of the disease (46). The development of 
chronic hepatitis after an HBV infection is dependent on several 
factors such as age (90-100% of infected neonates will become 
chronic, 20-30% of young children, and 5-10% of adults, 
4,6,27,77,125, 126), sex (men have a 1.5-2.0 times higher 
prevalence of developing chronic hepatitis than women, 80,105,125) 
and immunologic status (46,131). 
During the progress of chronic hepatitis three ma]or courses of 
serologic markers can be aistinguishea (46,81): (a) Persistence of 
HBeAg, whilst HBV DNA and DNA-p appear with elevated levels of 
serum transaminases indicating an ongoing active virus replication 
(16,52). (b) Loss of HBeAg, HBV DNA, DNA-p, and a seroconversion to 
anti-HBe in which some patients also seroconvert from HBsAg into 
anti-HBs and clear the disease, and the other patients show a 
remaining production of HBsAg and become "healthy" HBsAg carriers 
(61,96). (c) Loss of HBeAg and seroconversion to anti-HBe, but a 
subsequent intermittent reappearance of HBV replication markers, 
especially of HBV DMA (1,13,21), resembling a reactivation of acute 
viral hepatitis. These patients have the highest chance of 
developing cirrhosis and/or hepatocellular carcinoma (29,47). 
Viral replication is essential for the development of chronic 
hepatitis. however, the lack of correlation between the titer of 
HBV particles in serum and the activity and severity of the 
accompanying hepatitis suggests the existence of another important 
factor in the pathogenesis of the disease. This factor is most 
probably the host immune response (46,62,80,100,131). 
3.3 Hepatocellular carcinoma (HCC) and cirrhosis 
Indications of an association between persistent HBV infection and 
HCC have been obtained from epidemiologic studies, molecular 
investigations on HCCs, studies on cell lines derived from HCCs and 
studies on animals infected with hepadna viruses (63,84,93, 99). 
However, the direct molecular mechanism by which HBV induces the 
development of HCC is not yet clear. 
Epidemiologic findings supporting HBV infection as an etiologic 
factor in the development of HCC are: (a) The strong geographic 
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correlation between the prevalence of HCC and HBV infection. In 
countries where HBV infection is common, HCC is frequently found on 
autopsies and this malignant tumor has the highest prevalence of 
all cancers (124,125). (b) A close correlation between the 
prevalence of serum HBsAg and the occurrence of HCC, both in 
countries with a high incidence of HCC (such as African countries 
and the Far East) and a low one (11,49,124). (c) Patients with HCC 
have a higher frequency of HBsAg positive mothers than fathers, 
indicating that neonatal infection and subsequent persistent 
hepatitis lead towards HCC (5,143). (d) Prospective studies 
indicate that the relative risk of developing HCC is about 200-fold 
greater for the HBsAg positive people than it is for those that are 
HBsAg negative (4,7). 
In studies on the molecular level it has been demonstrated that HBV 
DNA can integrate in the host genome and thus may have a role in 
the onset of hepatocellular carcinoma (15,58,106,109), as shown 
with retroviruses (63,98,118). In addition, HBV DNA is present in 
an integrated form in various cell lines derived from HCC 
(23,56,67,139). Furthermore, significant rearrangements of cellular 
flanking regions and viral sequences have been found (112,115,149). 
These findings are consistent with observations on other oncogenic 
viruses (71,75). However, a common mechanism that may lead to the 
development of HCC by integration of viral DNA into the host genome 
has not been elucidated (14,40,44,63,99,111,119,133). 
In clinical studies it has been found that patients having liver 
cirrhosis are at high risk of developing HCC. However, many 
patients have HCC without any evidence of cirrhosis 
(4,7,83,94,125,147). This finding suggests that persistent HBV 
infection is the common denominator for the two different states 
(postnecrotic cirrhosis and HCC, which may coexist) rather than 
that liver cirrhosis is the etiologic condition for the development 
of HCC. 
Lieberman and Shafritz (63) proposed a model which describes the 
development of HCC (figure 3). In HBV carriers viral replication 
may continue or may stop while the HBV DNA integrates at random. 
HBV DNA in those patients would appear as a diffuse smear on a 
Southern blot analysis. Under certain unproved, but suspected 
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Fig.3 Speculative model showing events following infection with 
HBV and integration of the viral DNA into liver cell genome, 
which may lead to the development of HCC (see text for 
details). From Lieberman and Shafntz (63), with permission. 
conditions, such as superinfection of other viruses, hepatic damage 
by ethanol or other hepatotoxic substances, a series of cellular 
and/or viral rearrangements may occur, leading to altered 
phenotypic behavior of the hepatocytes. These cells may expand into 
groups of cells (clonal expansion) showing discrete bands in an 
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agarose gel. With further growth of such cells under stimulation of 
ajjjjropi late host or environmental circumstances autonomous 
neoplasias (HCC) may develop. 
5 POSTULATED MECHANISMS OF T-CELL CYTOLYSIS OF INFECTED HEPATOCYTES 
In acute hepatitis it is generally suggested that viral antigens 
are displayed on the cell surface of the infected hepatocytes. 
These cells are attacked by sensitized cytotoxic T-cells, causing 
the clinical symptoms of hepatocellular necrosis (34,131). Released 
and circulating virus particles are neutralized by the humoral 
antibodies preventing reinfection of other hepatocytes 
(lb,126,142). In the research dealing with the cellular immune 
response ample evidence has accumulated showing that especially the 
HBc-antigen-antibody-complex (and to a lesser extent the HBe-
antigen-antibody-complex, 91) on the hepatic cell membrane, 
together with HLA class I antigens, serves as a recognition site 
for the cytotoxic T-cells (26,33,34,76,86,136), probably mediated 
by interferon (107). 
In chronic hepatitis it is suggested that the host's immune system 
fails to eliminate hepatocytes supporting HBV replication, because 
of a reduced immune response and/or reduced HLA class I display 
(107), and the chronic infection is thus established (131). The 
very high percentages of the chronic carrier state in newborn in-
fants from HBV infected mothers could be explained by the fact that 
anti-HBc antibodies of the mother can pass the placental barrier, 
thus masking HBcAg display on the plasma membrane of the infected 
hepatocytes and preventing the cytolytic action of T-cells (91). 
If, during the course of chronic hepatitis, the virus is not 
cleared completely, the possibility of HBV DNA integration into the 
host genome increases. After integration the proper antigens for 
cytotoxic lysis are probably not exposed on the cell surface 
anymore, thus evading the immune elimination process (57,131). 
After malignant transformation those cells may be the onset of 
clonal growth and HCC. 
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6 IN VITRO PRODUCTION OF HEPATITIS В VIRUS PARTICLES 
The first trials to establish an in vitro virus replication system 
go back to the seventies when Noyes (82) and Brighton et al. (17) 
infected cultured fetal hepatocytes with infectious serum and found 
viral antigens by immuno fluorescence in the nucleus and cytoplasm 
of the cells, the nuclear signal being always earlier. However, 
efficiencies of infection were low and the studies showed no 
evidence of the production of infectious Dane particles. Other 
investigators were working on bone marrow cells with some proof of 
viral replication (35,14b), but closest to the real situation were 
the co-workers of Summers (138) who succeeded in infecting primary 
duck hepatocyte cultures with infectious duck serum and who found 
active virus replication (replicative DNA intermediates on a 
Southern blot) and were able to reinfect other cells with the m 
vitro obtained viral end products. Recently Shimizu et al. (113) 
succeeded in infecting cultured adult human hepatocytes with 
infectious serum, which revealed high numbers of HBsAg (20-30%) 
positive cells, but no DNA products were found that pointed towards 
complete viral replication. Some progress has been made by 
introducing cloned HBV DNA into hepatoma cells (24,108,137). In 
fact it is interesting to note that several other investigators 
have proved that virus production can be triggered in tumor cell 
lines with a comparatively high efficacy, provided that closed 
circular double stranded HBV DNA is introduced in the host cell 
nucleus by transfection with calcium chloride or electroporation 
(45,123). As mentioned before this double stranded form should be 
necessary to ensure a complete transcription (70,73,98). 
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7 BACKGROUND AND AIM OF THE PRESENT STUDY 
Since the discovery of the Australia antigen (HBsAg) by Blumberg 
in 1965 (10), significant advances in basic and clinical research 
of HBV infection have been achieved. Despite these advances, major 
gaps btill exist in our knowledge of the biology of HBV and the 
interaction of HBV with its natural host cells. In man, studies of 
the mechanism of viral replication and the pathogenesis of 
hepatocellular necrosis seen in chronic and acute HBV infection 
have been hampered by the lack of appropriate and well 
characterized specific in vitro techniques. In particular, a 
permissive cell culture system to propagate HBV has not been 
established. Efforts to infect non-human hepatocytes, cell cultures 
of non-hepatic origins and tumor cell lines failed and it became 
clear that organ and species specificity may be of importance in 
successfully creating viral infection. 
The aim of our study was, therefore, to establish a culture system 
of human hepatocytes as a natural host cell for HBV. This system 
will serve as a model for the study of the initial events of 
infection. Since a technique to detect viral DNA was necessary, the 
development of a relatively simple, but reliable, method tor the 
detection of viral DNA was also an important objective of this 
study. 
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CHAPTER II 
LRYOPKbSbRVATION OF ADULT HUMAN HUPATOCYTKS 
The influence of deep freezing storage on 
the viability, cell seeding, survival, 
fine structures and albumin synthesis 
in primary cultures 
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Summary 
Isolated and cultured human hepatocytes provide a useful model for studies of the liver cell function in man In 
vitro studies using human hepatocytes are scarce, due to the limited availability and the lack of suitable methods 
for storage In this study, we report the effect of deep freezing storage on the viability, fine structures and albu­
min synthesis of human adult hepatocytes in classical culture conditions Hepatocytes were isolated using colla-
genase perfusion (9 isolations) The cell yield was 4-37 x 10e with a viability of 6 0 - 8 7 % Cryopreservation was 
performed in medium containing 10% DMSO and 2 0 % fetal calf serum using a Cryoson BV-4 programmable 
freezer (0 °C for 5 mm, followed by a freezing rate of 1 5 °C/min for 20 mm and 7 °C/min for 10 mm) The cells 
were stored for 25-275 days in the liquid nitrogen vapor phase (-150 0C) Within 16 h about 8 0 % of viable cells 
from freshly isolated hepatocytes whereas after cryopreservation, 5 5 % of viable cells as determined by Trypan 
Blue exclusion before the cryopreservation attached to plastic and survived Electron microscopy showed well 
developed tight junctions, structures similar to bile canahculi Cell polarity was evident However, bleb' forma­
tion, more lipid droplets and lysosomes were found in cryopreserved hepatocytes during a short period after 
thawing At the 3rd week, cells detached and died These changes were associated with increased secretion of 
lactate dehydrogenase, whereas the albumin secretion dropped (from 10 to 4^g///g DNA), regardless of whether 
hepatocytes were cultured from fresh preparations or after cryopreservation These findings suggest the cryopre­
servation is a useful technique to preserve hepatocytes for in vitro studies Nevertheless, an improved method is 
necessary to increase the efficiency of cell seeding after cryopreservation 
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Introduction 
Isolated or cultured human hepatocytes provide a 
useful model for the study of specific metabolic func­
tions and the specific interaction and development of 
parasites or viruses in the liver cells in man Studies in 
vitro using human hepatocytes are, however, still 
scarce, mainly due to the limited availability of viable 
tissue and the lack of suitable methods for preserva­
tion and storage when the viable hepatocytes arc 
available 
Living cells from human or animal origins can be 
stored successfully for a long period of time if kept at 
very low temperature [1-5) Cryoprescrvation of rat 
hepatocytes has been described [6-8] The purpose 
of this study is to examine the influence of deep freez­
ing storage on the viability, cell seeding survival, 
fine structures and albumin synthesis of adult human 
hepatocytes in primary cultures 
Materials and Methods 
Materials 
L-[4,5-:!H]Leucine (76 Ci/mmol) and [6-14C]orotic 
acid (61 mCi/mmol) were obtained from the Radio­
chemical Centre, Amersham, Collagenase type I, 
bovine serum albumin, 4-(2-hydroxyethyl)-l-pipera-
zine ethanesulfomc acid (Hepes) were purchased 
from Sigma William's medium E and all sera were 
from Flow Laboratories Triton X-100 and sodium 
dodecyl-sulfate were obtained from BDH Chemicals 
Ltd FGTA (ethylene glycol-bis (/i-amino ethyl eth­
er) N.N.N'jN'-tetraacelic acid), EDTA (ethylene 
diamino tetraacetic acid), phenol, sodium deoxycho-
late, salts and solvents were purchased from E 
Merck Dexamethasone disodium phosphate (Ora-
dexon®), was obtained from Organon, The Nether­
lands 
Chemicals, unless otherwise specified were of ana­
lytical purity All glassware was sterilized and solu­
tions were freshly prepared and autoclavcd prior to 
use 
All solutions used in the hepatocyte isolation and 
culturing, were filtered through a 0 22-^m Milhpore 
filter and stored frozen 
Preparation of isolated hepatocytes 
Post-mortem human liver tissues were obtained 
from nine kidney donors aged from 16 to 51 years 
Hepatocytes were isolated by a two-step perfusion 
technique modified from that described for the isola­
tion of rodent hepatocytes [9] All procedures were 
performed under sterile conditions After organ or 
tissue removal, the liver was perfused through the 
large vessels on the cutting surface by syringe with 
ice-cold saline and subsequently placed in cold saline 
and kept on ice until the isolation procedure could be 
started (2-9 h after tissue removal) 
The liver sample, a part of the left lobe, weighing 
250-400 g surrounded by the hepatic capsule on all 
sides except for one cutting surface was used for the iso­
lation of hepatocytes The large branches of portal vein 
were cannulated with PVC tubings (non-toxic quali­
ty) and held in place by ligatures Approximately 
three liters of Ca2 + Mg2+-free Hepes buffer, pH 7 4, 
containing 0 5 mM EGTA was then perfused through 
the liver sample at a total rate of 150-200 ml/rmn 
(40-50 ml/min/tubing) As soon as the perfusion was 
started, it was observed that a great part of the liver 
sample began to blanch Subsequently, the liver sam­
ple was perfused with 200 ml of a Hepes buffer, pH 
7 6, containing 0 05% (w/v) collagcnase and "> mM 
CaCU in a recirculation system for 10 mm, and with 
100 ml Hepes buffer, pH 7 6, containing 0 1% (w/v) 
collagenase and 5 mM СаСІ2 for approximately 20 
mm The buffers were maintained at 37 "С and con­
tinuously gassed with oxygen (medical quality) 
After the collagcnase perfusion, the liver tissue 
was gently teared apart and cells were dispersed by 
shaking The loosened mass and cell suspension were 
then passed through 250-μΜ nylon filter The filtrate 
was cooled on ice and centrifuged at 50 x g for 5 mm 
at 4 °C The cell pellet was resuspended m cold 
Hepes-Tes (TES, 2-[2-Hydroxy-l,l-bis(hydroxy-
mcthyl)ethyl]amino ethane sulfonic acid) buffer, pH 
7 6, containing 2% bovine serum albumin (incuba­
tion buffer) and recentnfuged The pellet was again 
resuspended in cold incubation buffer and incubated 
in a shaking water bath (120 rpm) at 37 °C for 15 mm 
The cell suspension was then passed through 100-μΜ 
nylon filter and the viability of the hepatocytes was 
determined by Trypan Blue exclusion tests 
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Deep freezing storage of hepalocytes 
The isolated hepatocvtes were suspended in ice 
cold William's medium E containing 10% (v/v) di-
methylsulfoxide (DMSO) and 20% (v/v) fetal calf se­
rum in a density of 5-15 x 106 viable cells/ml Freezing 
was performed in storage vials (NUNC) using a 
Cryoson BV-4 programmable freezer Cooling was 
obtained by computer-controlled liquid nitrogen 
evaporation After a equilibration (5 mm) at a start­
ing temperature of 0 °C. temperature reduction was 
initiated at a rate of 1 5 °C/min for 20 mm followed 
by a freezing rate of 7 °C/min for 10 mm The cells 
were then stored in the liquid nitrogen vapor phase 
(-150 °C) for 25-275 days prior to use The freezing 
program was adapted from cryopreservation of hu­
man bone marrow progenitor cells for autologous re-
mfusion [10] 
Thawing of frozen hepalocytes 
Hepatocytes were thawed by immersion of a stor­
age vial in a 37 0C water bath Immediately after 
thawing, cells were diluted rapidly at 4 "C with cul­
ture medium and washed twice to remove the cryo-
protectant by centnfugation at 50 x g for 5 mm The 
Trypan Blue exclusion tests were then performed on 
thawed cells 
Cell cultures 
The culture medium was William's medium E sup­
plemented with 10% (v/v) fetal calf serum, 2 mM L-
glutamine, 20μ/πι1 porcine insulin, 50 η M dexameth-
ason, 2 5 Ug/ml fungizone, 50/ig/ml gentamycine, 5 
¿ig/ml tetracycline and 100 ¿<g/ml vancomycine He-
patocytes (frozen or non-frozen) were seeded at a 
concentration of 175 x 103 cells/cm2 in polvstjrene 
flasks or dishes and maintained in a humidified atmo-
sphere composed of 95% air and 5% CO2 The medi-
um was renewed 12 h after cell seeding and every 24 
h thereafter 
Attachment efficiency 
The attachment efficiency of hepatocytes was de-
termined 12-16 h after plating The culture medium 
was removed after gentle shaking The culture dishes 
were then washed twice with Hanks' balanced salt so-
lution (HBSS), pH 7 4 Attached cells were har-
vested by disrupting the monolayer with a rubber po-
liceman in HBSS 
After washing by centnfugation at 50 x g for 5 
mm, the amount of DNA was determined (see be-
low) The attachment efficiency was calculated by di-
viding the amount of DNA of attached cells/dish 12 h 
after plating with the amount of DNA of total viable 
cells seeded/dish at time zero The viable cells were 
determined by Trypan Blue exclusion test on isolated 
hepatocytes before cryopreservation 
DNA determination 
Cells were suspended in water and sonicated Af-
ter centnfugation, DNA in supernatant was mea-
sured by a fluorometnc technique as described by 
Kapuscinski and Skoczylas [11] 
Incorporation of labelled precursor into RNA 
[6-14C]Orotic acid (61 mCi/mmol) was added to the 
cell culture medium (3 μΟ/πιΙ) At the indicated 
times, cells of duplicate wells were washed and har­
vested with Hank's balanced salt solution Hundred 
μ\ samples were spotted onto 2 3-cm Whatman 3MM 
filter paper discs, which were immersed in cold 10% 
trichloroacetic acid containing 5 mM sodiumpyro-
phosphate Filters were washed to remove free la­
belled precursor as described [12] RNA precipitates 
were solubihzed from the filters by treatment with 2 
x 1 ml of 30% H202/35% NH, solution (17 3, v/v) for 
10 h at 55 "C, and counted for radioactivity in 10 ml 
of Aqualuma plus (Lumac), giving a counting effi­
ciency of 41% 
Incorporation of labelled precursor into protein 
pHlLeucine (5 /¿Ci/ml) was added to the cell cul-
ture medium At the indicated times, duplicate 50-/Л 
samples were withdrawn from the medium and 
spotted on 2 3-cm Whatman 3MM filter-paper discs, 
which were immersed in cold 10% trichloroacetic 
acid containing 5 mM leucine Filters were washed to 
remove free labelled precursor as described by Mans 
and Novelli [13] Protein precipitates were solubi-
lized from the filters and counted for radioactivity as 
described previously 
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Albumin assay 
The amount of albumin secreted into the medium 
was determined bv radial immunodiffusion technique 
as described bv Mancini et al [14] There is no de­
tectable cross-reactmty with other proteins present 
in the culture medium including bovine serum albu­
min 
For the albumin determination, the culture medi­
um was 10 times concentrated using Amicon BI5 
(Minicon) concentrator (Amicon, Danver, MA) 
Lighl microscopy 
Cells were seeded on glass covershps At the indi­
cated times cells were fixed with methanol for 30 
mm Staining was performed in 10% (v/v) Giemsa so­
lution (Merck, Darmstadt, F R G ) for 10 mm The 
covershps were then immersed 3 times 5 mm in tert -
Butanol (Merck, Darmstadt, F R G ) and 2 times 5 
mm in xylol and mounted with Permount (Fisher, 
Fair Lawn, NJ, U S A ) 
Electron microscopy 
Freshly isolated, thawed and cultured hepatocytes 
were fixed in situ with 2 0% glutaraldehyde contain­
ing 0 15 M cacodylate buffer pH 7 4 for 30 mm at 
4 °C, postfixed in a 1% (v/v) osmium tetroxide solu­
tion in 0 15 M cacodylate buffer, pH 7 4, for 60 mm 
at 4 "C, dehydrated by ethanol and propylene oxide 
and embedded in Epon (EMS, Fort Washington, 
NY) Epon was polvmenzed for 24 h at 30 °C and for 
another 24 h at 60 °C For these ultrastructural stud­
ies, cells were seeded in Lux Contur Permanox tissue 
culture dishes (Flow, Irvine, Scotland) at a cell den­
sity of 175 x lO^cm2 
Enzyme assays 
Aspartate amino transferase (AST), alanine 
aminotransferase (ALT), lactate dehydrogenase 
(LDH), alkaline phosphatase (AP) and gamma-glu-
tamyl transpeptidase (GGT) were determined in cul­
ture medium according to the routine clinical labora­
tory methods 
Results 
The major difficulty of cell isolation from adult hu­
man liver was encountered due to the size of the or­
gan and the relative high content of fibrous tissue in 
human liver To overcome these difficulties, we have 
modified the in situ two-step collagenase perfusion 
technique for the isolation of hepatocytes from ro­
dent liver into a procedure applicable for the isola­
tion of human hepatocytes 2-9 h after tissue remo-
TABLE 1 
THF INFLUENCE OF DEEP FREEZING STORAGE ON ТНГ VIABILITY OF ISOLATED HUMAN ADULT HEPATO 
CYTES AS MEASURED BY 7 RYPAN BLUE EXCLUSION 
Donor 
8 
9 
Range 
Mean 
Sex 
(F/M) 
F 
M 
M 
M 
F 
M 
M 
M 
M 
Age 
(yr) 
19 
l i 
20 
20 
22 
51 
20 
20 
16 
16-51 
24 8 
Isolated hepalocy 
Viability 
№ 
75 
81 
60 
80 
60 
80 
75 
87 
80 
60-87 
75 3 
les 
Duration of deep 
freezing storage 
(days) 
275 
241 
m 
163 
158 
127 
60 
42 
25 
25-275 
140 4 
Viability after 
cryopreservalion 
(%) 
58 
55 
44 
57 
48 
57 
58 
66 
70 
44-70 
57 
Relative decrease 
of viability 
(%) 
23 
32 
19 
19 
20 
29 
23 
21 
13 
13-32 
22 
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val. The cell yield obtained from the left lobe or a 
part of the left lobe was ranging from 4 to 37 x 108 
viable cells. The viability as determined by Trypan 
Blue exclusion tests was 60-87%. The cell diameter 
estimated by microscopic measurement using a cali­
brated grid ranged from 16 to 19 ^m. The protein 
content was 500 ± 16 (SEM) ^g/106 cells. 
Viability and attachment efficiency 
Table 1 demonstrates the effect of deep freezing 
storage on the viability of hepatocytes. Frozen cells 
have been stored for 25-275 days prior to experi­
ments. After thawing, the viability of hepatocytes as 
determined by Trypan Blue exclusion was 15-30% 
lower than the values for freshly prepared hepato­
cytes. Accordingly, the attachment efficiency of 
cryopreserved hepatocytes was decreased (Fig. 1). 
Within 16 h about 80% of viable cells from freshly 
isolated hepatocytes, whereas after cryopreservation 
55% of viable cells as determined by Trypan Blue ex­
clusion before the cryopreservation attached to plas­
tic and survived. The DNA content in the tissue cul-
Fig. I. The effect of cryopreservation on the attachment effi-
ciency and survival of human adult hepatocytes in primary cul­
tures. Determination of attachment efficiency and DNA con­
tent were as described in Materials and Methods Each point is 
the mean measurement ± SD of at least 5 experiments Ί he in­
creased content of DNA at the last week of experiment was due 
to fibroblastic proliferation Freshly prepared hepatocytes 
( · · ) . cryopreserved (Δ Δ). 
Fig. 2. Light micrograph of human adult hepatocytes in primary culture. 48 h after cell seeding Hepatocytes were fixed with methanol 
and stained with Giemsa solution as described in Materials and Methods Hepatocytes had formed the confluent monolayer of polygo­
nal shaped cells with granular cytoplasm The nuclei contained prominent nucleoli x44() 
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tures was increased in the 3rd week of culture due to 
fibroblast proliferation (Fig. 1). 
Morphology and fine ilructiires 
After 12 h in culture, attached hepatocytes had 
formed the confluent monolayer of polygonal shaped 
cells with granular cytoplasm, regardless of whether 
hepatocytes had been frozen or not (Fig. 2). The nu­
clei (1-2/cell) contained prominent nucleoli On tis­
sue culture plastic, attached hepatocytes spread and 
showed morphological characteristics without no­
ticeable differences between frozen and non-fro/en 
cells. After 1 week, cell morphology was less regular 
and hepatocytes flattened with multiple cytoplasmic 
projections. At the 4th week, frozen and non-frozen 
cells detached and died. Electron microscopy of he­
patocytes immediately after isolation showed a well-
preserved ultrastructure. However, the classical bil­
iary polarity — the presence of Golgi complexes and 
lysosomes in the cytoplasm near the bile canahculi — 
was completely lost (Fig. 3). The rough endoplasmic-
reticulum and mitochondria were uniformly distri­
buted. Smooth endoplasmic reticulum and glycogen 
¡naopiasimc reticulum ana giycogt 
»••»г·.»» .Λ 't., ' ^ 
Fig. 3. Transmission electronmicrograph of a human aduli he-
patoevte immcdiatcK alter isolation Nucleus (N|. mitochon­
drion (M). rough endoplasmic reticulum (R) and smooth en­
doplasmic reticulum (S) were very well preserved Fat droplets 
(F) were also demonstrated x6 050 
if/-1$ * ь* 
- i · ÉL/rr^M .- Vi? 
I л. ^іщ ν» » г % 
В 
Fig. 4. Transmission electronmicrogr.iphs of human adult hepatocytes after crvoprcscnation Electronmicrographs were performed 
4 h after thawing cell without M) and with(ßl bleb formation Mitochondria (M) were umformh distributed The cvtoplasmic pro-
trusions (blebs. S) were filled with ground substances 
4C 
CRYOPRESERVATION OF ADULT HUMAN HEPATOCYTES 
Fig. 5. Transmission electronmicrographs of non-frozen human adult hepatocytes after 75 h of culture m a polystyrene flask Lyso-
somes (L). and Golgi apparatus (G) were distributed around structures similar to bile canaliculi (ВС) Structures similar to tight junc­
tions (TJ) could also be observed .4 x4 090: S; detail. x9 000 
Fig. 6. Transmission electronmicrographs of cryopreserved human adult hepatocytes after 50 h of culture in a polystyrene flask The 
formation of structures similar to bile canaliculi as described in Fig 5 could also easilv be observed and was associated with the 
reconstitution of a Golgi biliar} polariU (arrow) A x 1 530: B: detail of structure similar to bile canaliculus with microvilli. xl6 200 
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particles were easv to identifv Frozen cells immedia 
telv after thawing demonstrated little changes in 
comparison to the ultrastructural features of non-fro­
zen hepatocytcs Nevertheless, bleb formation was 
observed in approximately 10-20'* of the cells (Fig 
4) 
Within 12 h of incubation the initial spherical liver 
tells aggregated and formed cell plates of polygonal 
hepatocytes Newlv formed bile canahculi with nu­
merous microvilli were reconstituted within 2-1 
davs Structures similar to tight junctions could also 
be observed The development of bile canaliculi and 
tight junctions was found in cultures of frozen and 
non-frozen hepatocvtes (Figs S and 6) The forma­
tion of bile canaliculi was associated with the re-
constitution of a Golgi biliary polarity Golgi com­
plexes and Ivsosomes were found in close association 
with the bile canahculi 1 he rough endoplasmic retic­
ulum was located in the vicinity of the cell nucleus 
After 1 week hepatocytes revealed a high degree of 
flattening with cytoplasmic projection In cultures of 
frozen hepatocvtes cells exhibited more lipid drop­
lets and Ivsosomes than in cultures of non-frozen he­
patocytes Alter 2 or 1 weeks the typical ultrastruc­
tural characteristics of hepatocytes were gradually 
lost regardless of whether hepatocytes had been fro­
zen or not (figures not shown) 
Protein and albumin s\ntheiis 
To characterize the capabilities of cultured hepa­
tocytcs to synthesize RNA and protein, incorpora­
tion of labelled precursor into RNA and protein was 
studied Incorporation of [6-14C|orotic acid into 
RNA of frozen and non fro/en hepatocytcs cultured 
for 24 h was found at a linear rate for 24 h However 
frozen hepatocytes showed a slightly lower incorpo­
ration as compared to that of non frozen cells (Fig 
7) The incorporation of ['Hjleucine into secreted 
protein continued also at a linear rate for over 30 h 
(Fig 8) Following this period the net release of la­
belled protein was reduced as previously described in 
isolated rat hepatocytes [H] 
The incorporation of ['HJIeuLinc into secreted pro 
tein was found slightly higher in cultures of non-fro­
zen hepatocytes than that of frozen hepatocvtes 
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С O f J Ö ι ι- Ρ 3(ed f M j 
. а RS.U "PW ре мЭ ' ^ Δ 
600 -ι 
θ \? 16 20 ?ί ?β 3J 
Fig 7 Incorporation οΓ [6 |JC]oroiic acid mio RNA of hu­
man adult hepatocjti-s in primarv culturLs f.ich point on the 
curves is the average value ± SD obtained from hepatocytes 
(C O) and cryoprtserved hepatocytes (A A) Expe­
riments were performed at 72 h after cell seeding 
J. Б ^Hjleucine mcorporaled mio 
secreted protein (DPMwlO : , p e r ^ g D N A ) 
600 η 
t i m e ! h ) 
Fig 8 Incorporation of [4 S-'HJleucme into secreted protein 
of human adult hepatocvtes in pnm.m cultures Each point 
on the cunes is the average value ± SD obtained from hepa­
tocvtes of at least 4 experiments Non-frozen hepatocytes 
(O O) and crvopreserved hepatocytes (A A) Expe­
riments were performed at 72 h after cell seeding 
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The albumin secretion of hepatocvtes (frozen and non frozen hepatocytes the albumin secretion 
non frozen) cultured for 3 weeks is demonstrated in dropped from 10 μ%Ιμί D N A to 6 μ%)μξ, D N A This 
Fig 9 During the first week of culture of frozen or decreased albumin secretion was associated with a 
A S A T — A L A T · -
(mU/ijgDNA) 
A 320 
280 
A l b u m i n · — L D H -
Í ¿jg/pgDNA: (mU/>jgDNA) 
*• i 
A S A T - · 
(mU/)jgDNA) 
В 3?0-
10 12 14 16 18 20 
culture t me ( days ) 
Albumin·—· L D H 
r
.... L . «. ,. ι ^ ^ » ^ T - f r f T ^ - T T ^ 
mU/pgDNA) 
10 12 14 16 ÍS 20 
Culture lime (days) 
Fig 9 The albumin secretion and enzyme activities in medium of human aduli hepatocytes in pnmary cultures A non frozen hepato 
cytcs В cryopreserved hepatocytes Each point on the curves is the average value ± SD obtained from hepatocytes of at least 6 expe 
nments Aspartate aminotransferase (ASAT) alanine aminotransferase (ALAT) and lactate dehydrogenase (LDH) were deter 
mined according lo the routine clinical laboratory methods 
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diminished activity of transaminases in the culture 
medium In this period the lactate dehydrogenase 
(LDH) in culture medium was not detectable or at a 
very low level After this period, this enzyme activity 
was gradually increased with a peak at the end of the 
2nd week for non-frozen hepatocytes and a peak at 
the end of the 3rd week for frozen hepatocytes In 
contrast to non-frozen hepatocytes the increased 
LDH activity in cultures of frozen hepatocytes was 
not accompanied by an enhanced activity of trans­
aminases in culture medium The albumin secretion 
was still detectable (4-6 ¿ig//ig DNA) after 3 weeks 
of culture regardless of whether hepatocytes had 
been frozen or not The activities of gamma glutamyl 
transpeptidase (GGT) and of alkaline phosphate 
(AP) in culture medium of frozen hepatocytes were 
not different from those of non-frozen hepatocytes 
and found between 1 and 3 mU//ig DNA for GGT and 
between 3 and 15 mU.Vg DNA for AP in the 3-week 
period of experiments 
Discussion 
Primary cultures of hepatocytes have been extensi-
vely used in in vitro systems for the study of specific 
metabolic function of the liver, hormonal regulation 
and biotransformation of drugs and genotoxic com-
pounds Cultured hepatocytes have also been used 
for cultivating malaria parasites in a better under-
standing of the pathobiology of this infectious disease 
[16-18) From the studies using hepatocytes ob-
tained from various animal species, it has become 
evident that marked differences exist between spe-
cies in the metabolism of and or susceptibility to 
drugs, genotoxic agents or parasites and other micro-
organisms [19-22] Although human hepatoma cell 
lines under certain circumstances could be used, pri-
mary cultures of normal human hepatocytes seem to 
be a more attractive approach for studying specific 
functions of the liver and specific interaction between 
liver cells and infectious agents such as hepatitis В vi­
rus in man 
In our laboratory, we have utilized human hepato­
cytes in vitro for the study of activation of mutagens 
and drug metabolism [19] and for the study of ultra-
structural organization of liver stages of Plasmodium 
falciparum [17] As with most differentiated cells, 
human hepatocytes exhibit rapid phenotypic changes 
resulting in alterations of specific cell functions in vit­
ro [23,24] Since they have been isolated from valu­
able and infrequent tissue samples, there is a need for 
a suitable method for storage of these isolated hepa­
tocytes for a long period of time A successful storage 
regimen would yield slocks of cells that can be re­
stored to full activity at any time 
Cryopreservation has been described for a variety 
of mammalian cells including human bone marrow 
progenitor cells for autologous reinfusion [1-8,10] 
For the cell survival after thawing, the composition of 
freezing medium (cryoprotectant) and the cooling 
rate are very critical [6,25] In addition, DMSO tox­
icity may influence the cell survival after thawing Al­
though cryopreservation of rat hepatocytes by slow 
and rapid freezing rate has been described [6], in this 
study the freezing program was adapted from cryo­
preservation of human bone marrow progenitor cells 
[10] Under this condition using 10% dimethylsulfox-
ide as cryoprotectant, a 10-30% reduction in viabili­
ty and attachment efficiency of hepatocytes had been 
found This finding is comparable with the results ob­
tained from rat hepatocytes [6,7] 
Although the freezing procedure resulted in some 
degree of 'bleb' formation and a lower attachment ef­
ficiency, attached hepatocytes survived and behaved 
as non-frozen hepatocytes Bleb formation had been 
described as the result of cell isolation [26], however, 
the freezing procedure may increase this phenome­
non [27] Despite this 'bleb' formation of frozen he­
patocytes, after 12 h in culture, no morphological dif­
ferences could be observed between frozen and non-
frozen cells Frozen and non-frozen hepatocytes un­
der the classical culture condition using fetal calf se­
rum supplemented medium and plated onto polysty­
rene plastic dishes reconstituted structures similar to 
bile canalicuh with junctional complexes within 2 
days The duration of deep freezing storage had no 
influence on cell survival 
The rate of albumin secretion, as a typical liver cell 
function, in cultures of frozen and non-frozen hepa-
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tocytes was also similar despite more lipid droplets 
and lysosomes were found in frozen than in non-fro­
zen hepatocytes after 1 week of culture and there was 
a delay of increased level of lactate dehydrogenase 
activity and a lack of transaminase secretion in medi­
um of frozen hepatocytes in the 2nd and 3rd week of 
culture Recently, cultivating the liver stages of Plas­
modium falciparum has also been successfully car­
ried out using cryopreserved hepatocytes [28] From 
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CHAPTER III 
THE INFLUENCE OF LIVER EXTRACELLULAR 
MATRIX ON LONG-TERM CULTURES OF NORMAL ADULT 
HUMAN HEPATOCYTES 
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ABSTRACT. Cultured human hepatocytes provide a useful model 
for studies of specific metabolic functions and specific in­
teraction and development of parasites or viruses in the li­
ver cells in man. Studies in vitro using human liver cells 
are, however, still scarce, mainly due to the limited availa­
bility of viable tissue and the lack of methods for preserva­
tion and storage when viable hepatocytes are available. In 
addition, normal adult hepatocytes are not able to prolifera­
te in vitro using culture conditions established so far. Pre-
viously, we have shown that living human hepatocytes can be 
stored for a long period of time by cryopreservation. Howe­
ver, after thawing the efficiency of cell seeding onto the 
plastic dish and accordingly the survival rate of hepatocytes 
in primary cultures were decreased as compared to the freshly 
prepared hepatocytes. Furthermore, under the classical cultu­
re condition, hepatocytes exhibit rapid phenotypic changes 
and die. 
In this study, we report the effect of extracellular matrix 
(ECM) prepared from adult human liver on the cell seeding, 
survival, some metabolic functions, and on the fine structu­
res of human hepatocytes especially after cryopreservation in 
primary cultures. The deleterious effect of freezing storage 
on attachment and survival of hepatocytes can be significant­
ly abolished by using tissue culture plastic precoated with 
liver ECM. Under this culture condition, hepatocytes survived 
longer than 4 to 6 weeks without evidence of fibroblast pro­
liferation. Although the differences were statistically not 
significant, because of the individual variations, hepatocy­
tes seeded on liver ECM incorporated labelled precursors into 
RNA and into secreted protein at a faster rate. The albumin 
secretion was also higher and hepatocytes maintained their 
cuboidal morphology and typical fine structures for at least 
2 weeks longer than hepatocytes attached to plastic. 
These findings suggest that liver ECM is very useful to im­
prove the attachment efficiency and survival particularly of 
cryopreserved human hepatocytes in primary cultures. It pro­
longs the survival and the maintenance of typical phenotypic 
expression and the ability to secrete high levels of albumin. 
In addition, liver ECM prevents the proliferation of fibro­
blasts in tissue cultures. 
ISTRODOCTIOH 
For the study of specific metabolic functions and the specific 
interaction and development of parasites or viruses (such as he­
patitis В virus and non А поп В viruses) in the liver cells in 
man, it seems suitable and very attractive to use isolated or 
primary cultures of human hepatocytes. Studies in vitro using 
human liver cells are, however, still scarce, mainly due to the 
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limited availability of viable tissue and the lack of methods for 
preservation and storage when viable hepatocytes are available. 
In addition, normal adult hepatocytes are not able to proliferate 
in vitro using culture conditions established so far. 
In a previous paper (1), we have shown that living normal human 
hepatocytes can be stored for a long period of time by cryopre-
servation. However, after thawing the efficiency of cell seeding 
onto the plastic dish and accordingly the survival rate of hepa­
tocytes in primary cultures were decreased (15-30%) as compared 
to the freshly prepared hepatocytes. Furthermore, under the clas­
sical culture condition, hepatocytes exhibit rapid phenotypic 
changes and die. 
Since substrata of extracellular matrix (ECM) have been reported 
to improve the attachment of rat hepatocytes and the maintenance 
of specific cellular functions in primary cultures (2), the aim 
of our present study was to investigate the influence of liver 
extracellular matrix on the cell seeding, survival, synthesis of 
RNA and secreted protein, albumin secretion, and on the morpholo­
gy and fine structures of human hepatocytes especially after cry-
opreservation in primary cultures. 
MATERIALS AND METHODS 
Materials: 
L-[4,5-3H] Leucine (76Ci/mmol) and [б-14с] orotic acid 
(61mCi/mmol) were obtained from the Radiochemical Centre, 
Amersham. Collagenase type I, bovine serum albumin, 4-(2-hydroxy-
ethyl)-l-piperazine ethanesulfonie acid (Hepes) and TES (2-[2-Hy-
droxy, 1,1-bis (hydroxy-methyl) ethyl] amino ethane sulfonic 
acid) were purchased from Sigma. William's medium E and fetal 
calf serum were from Flow Laboratories. Triton X-100 and sodium 
dodecyl-sulfate were obtained from BDH Chemicals Ltd. EGTA (ethy­
lene glycol-bis (/3 amino ethyl ether) N, N, N 1, N'-tetra acetic 
acid), EDTA (ethylene di amino tetra-acetic acid), phenol, sodium 
deoxycholate, salts and solvents were purchased from E. Merck. 
Dexamethasone disodium phosphate (OradexonR), was obtained from 
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Organon, The Netherlands. 
Chemicals, unless otherwise specified, were of analytical purity. 
All glassware was sterilized and solutions were freshly prepared 
and autoclaved prior to use. 
All solutions used in the hepatocyte isolation and culturing were 
filtered through a 0.22 μια Millipore filter and stored frozen. 
Preparation of isolated hepatocytes: 
Post mortem human liver tissues were obtained from nine kidney 
donors aged from 16 to 51 years. Hepatocytes were isolated by a 
two-step perfusion technique modified from that described for the 
isolation of rodent hepatocytes. All procedures were performed 
under sterile conditions. After organ or tissue removal, the li­
ver was perfused through the large vessels on the cutting surface 
by syringe with ice-cold saline and subsequently placed in cold 
saline and kept on ice until the isolation procedure could be 
started (two to nine hours after tissue removal). 
The liver sample, a part of the left lobe weighing 250 to 400 
grams surrounded by the hepatic capsule on all sides except for 
one cutting surface, was used for the isolation of hepatocytes. 
The large branches of the portal vein were cannulated with PVC 
tubings (non toxic quality) and held in place by ligatures. 
Approximately three liters of CA + + Mg + + free Hepes buffer pH 
7.4, containing 0.5 mM EGTA was then perfused through the liver 
sample at a total rate of 150-200 ml per minute (40-50 ml per 
min. per tubing). As soon as the perfusion was started, it was 
observed that a great part of the liver sample began to blanch. 
Subsequently, the liver sample was perfused with 200 ml of a 
Hepes buffer pH. 7.6 containing 0.05% (w/v) collagenase and 5 
mM СаСІ2 in a recirculation system for 10 minutes, and with 100 
ml Hepes buffer pH 7.6 containing 0.1% (w/v) collagenase and 5 
mM СаСІ2 for approximately 20 minutes. The buffers were main­
tained at 37°С and continuously gassed with oxygen (medical qua­
lity). 
After the collagenase perfusion, the liver tissue was gently tea-
red apart and cells were dispersed by shaking. The loosened mass 
and cell suspension were then passed through a 250 jiM nylon fil-
51 
ter. The filtrate was cooled on ice and centrifuged at 50xg for 5 
minutes at 40C. The cell pellet was resuspended in cold Hepes-Tes 
buffer pH 7.6 containing 2% bovine serum albumin (incubation buf­
fer) and recentri fuged. The pellet was again resuspended in cold 
incubation buffer and incubated in a shaking water bath (120 rpm) 
at 37° С for 15 minutes. The cell suspension was then passed 
through 100 дМ nylon filter and the viability of the hepatocytes 
was determined by Trypan Blue exclusion tests. 
Deep freezing storage of hepatocytes; 
The isolated hepatocytes were suspended in ice cold William's 
medium E containing 10% (v/v) dimethylsulfoxide (DMSO) and 20% 
(v/v) fetal calf serum in a density of 5 to 15 χ IO6 viable 
cells per ml. Freezing was performed in storage vials (NUNC) 
using a Cryoson BV-4 programmable freezer. Cooling was obtained 
by computer controlled liquid nitrogen evaporation. After an 
equilibration (5 minutes) at a starting temperature of 0oC, tem­
perature reduction was initiated at a rate of 1.5° С per minute 
for 20 minutes followed by a freezing rate of 7°С per minute for 
10 minutes. The cells were then stored in the liquid nitrogen va­
por phase (-1500C) for 25 to 275 days prior to use. The freezing 
program was adapted from cryopreservation of human bone marrow 
progenitor cells for autologous reinfusion (1). 
Thawing of frozen hepatocytes; 
Hepatocytes were thawed by immersion of a storage vial in a 37°С 
water bath. Immediately after thawing, cells were diluted rapidly 
at 4° С with culture medium and washed twice to remove the cryo-
protectant by centrifugation at 50xg for 5 minutes. The Trypan 
Blue exclusion tests were then performed on thawed cells. 
Cell cultures; 
The culture medium was William's medium E supplemented with 10% 
(v/v) fetal calf serum, 2 mM L-glutamine, 20 mU/ml porcine in­
sulin, 50 nM dexamethasone, 2.5 pg/ml fungizone, 50 pg/ml genta-
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mycine, and 100 μ9/Γη1 vancomycin. Hepatocytes (frozen or nonfro­
zen) were seeded at a concentration of 175 χ 1θ3 cells per 
cm2 in polystyrene flasks or dishes coated with extracellular 
biomatrix and maintained in a humidified atmosphere composed of 
95% air and 5% CO2. The medium was renewed 12 hours after cell 
seeding and every 24 hours thereafter. 
Preparation of cell culture substrate: 
Extracellular biomatrix (ECM) from normal adult human liver, 
Wistar rat liver and rat tail tendon were prepared according to 
the method as described by Price et al. (3) and Rojkind et al. 
(4) with slight modification. After isolation, the extracellular 
matrix was lyophylized and dissolved in 0.1 M acetic acid in a 
concentration of 200 μg protein per ml. This suspension was laye­
red on culture plastic (20 ug/cm2) and the acetic acid was eva-
porized. The culture plastic precoated with ECM was washed with 
Hanks' balanced salt solution prior to use. 
Attachment efficiency; 
The attachment efficiency of hepatocytes was determined 12 to 16 
hours after plating. The culture medium was removed after gentle 
shaking. The culture dishes were then washed twice with Hanks 
balanced salt solution pH 7.4 (HBSS). Attached cells were harves­
ted by disrupting the monolayer with a rubber policeman in HBSS. 
After washing by centrifugation at 50xg for 5 minutes, the amount 
of DNA was determined (see below). The attachment efficiency was 
calculated by dividing the amount of DNA of attached cells per 
dish 12 hours after plating by the amount of DNA of total viable 
cells seeded per dish at time zero. For the calculation of at­
tachment efficiency of cryopreserved hepatocytes the viable cells 
were determined by trypan blue exclusion test on isolated hepato­
cytes before cryopreservation. 
DNA determination: 
Cells were suspended in water and sonicated. After centrifuga-
53 
tion, DNA in supernatant was measured by a fluorometric technique 
as described by Kapuscinski and Skoczylas (5). 
Incorporation of labelled precursor into RNA: 
[б-14] orotic acid (61 mCi/mmol) was added to the cell culture 
medium (ЗцСі/тІ). At the indicated times, cells of duplicate 
wells were washed and harvested with Hanks balanced salt solu­
tion. 100 ul samples were spotted onto 2.3 cm Whatman 3 MM filter 
paper discs, which were immersed in cold 10% trichloroacetic acid 
containing 5 mM sodiumpyrophosphate. Filters were washed to remo­
ve free labelled precursor as described by Mans and Novelli (6). 
RNA precipitates were solubilized from the filters by treatment 
with 2x1 ml of 30% Η2θ2/35% NH3 solution (17:3, v/v) for 
10 h at 55°C, and counted for radioactivity in 10 ml of Aqualuma 
plus (Lumac), giving a counting efficiency of 41%. 
Incorporation of labelled precursor into protein: 
[Зн] leucine(5pCi/ml) was added to the cell culture medium. At 
the indicated times, duplicate 50 μΐ samples were withdrawn from 
the medium and spotted on 2.3 cm Whatman 3 MM filter-paper discs, 
which were immersed in cold 10% trichloroacetic acid containing 5 
mM-leucine. Filters were washed to remove free labelled precursor 
as described by Mans and Novelli (6). Protein precipitates were 
solubilized from the filters and counted for radioactivity as 
described previously (7). 
Albumin assay: 
The amount of albumin secreted into the medium was determined by 
radial immunodiffusion technique as described by Mancini et al. 
(8). There is no detectable cross-reactivity with other proteins 
present in the culture medium including bovine serum albumin. 
For the albumin determination, the culture medium was lOx concen­
trated using Amicon BI5 (Minicon) concentrator (Amicon, Danver, 
MA). 
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Light microscopy; 
Cells were seeded on glass coverslips. At the indicated times 
cells were fixed with methanol for 30 minutes. Staining was per­
formed in 10% (v/v) Giemsa solution (Merck, Darmstadt, 
W.Germany) for 10 minutes. The coverslips were then immersed 
three times 5 minutes in tert-Butanol (Merck, Darmstadt, 
W-Germany) and two times 5 minutes in xylol and mounted with 
Permount (Fisher, Fair Lawn, NJ, USA). 
Electron microscopy: 
Freshly isolated, thawed and cultured hepatocytes were fixed in 
situ with 2.0% glutaraldehyde containing 0.15 M cacodylate buffer 
pH 7.4 for 30 minutes at 40C, postfixed in a 1% (v/v) osmium 
tetroxide solution in 0.15 M cacodylate buffer pH 7.4 for 60 mi­
nutes at 40C, dehydrated by ethanol and propylene oxide and em­
bedded in Epon (EMS, Fort Washington, NY, USA). Epon was polyme­
rized for 24 hours at 30°С and for another 24 hours at 60°C. For 
these ultrastructural studies, cells were seeded in Lux Contur 
Permanox tissue culture dishes (Flow, Irvine, Scotland) at a cell 
density of 175 χ 103 per cm2. 
Table 1. Attachment efficiency and survival of cryopreser-
ved human hepatocytes in primary culture on different sub­
strata . 
Attachment efficiency or survival was calculated as % of DNA 
content of viable cells* seeded per dish at time zero (avera­
ge of 3 experiments). 
Days after cell seeding 
Tissue culture plastic 
Collagen Type I (rat 
tail tendon) 
Extracellular matrix 
(rat liver) 
Extracellular matrix 
(human liver) 
Day 1 
51 
55 
63 
68 
Day 4 
43 
51 
55 
62 
Day 10 
40 
47 
52 
60 
Day 14 
35 
43 
49 
58 
•viable cells were determined by trypan blue exclusion test 
on hepatocytes before cryopreservation. 
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Enzyme assays: 
Aspartate amino transferase (ASAT), alanine aminotransferase 
(ALAT), lactate dehydrogenase (LDH), were determined in culture 
medium according to the routine clinical laboratory methods. 
RESULTS 
To examine the influence of extracellular matrix on the long-term 
cultures of normal adult human hepatocytes, freshly prepared as 
well as cells after cryopreservation were used. Cryopreserved he­
patocytes had been stored for 25 to 275 days prior to experi­
ments. The viability of hepatocytes as determined by trypan blue 
exclusion test was decreased from average 75% (60-87%) to 57% 
(44-70%) due to the cryopreservation procedure (1). Consequently, 
the attachment efficiency with a cell density of 175 χ 10^ 
cells per cm2, onto the plastic dish was also reduced to 85-70% 
of that of freshly prepared hepatocytes. 
Attachment efficiency and survivait 
In table I, the effect of different substrates on the attachment 
efficiency of cryopreserved hepatocytes is demonstrated. After 12 
hours in culture, the hepatocytes have a lower attachment and 
survival efficiency on tissue culture plastic than on plastic 
dishes precoated with extracellular matrix. The differences in 
substrates became increasingly apparent in the studies on the 
long-term cultures. The number of hepatocytes cultured on plastic 
declined gradually. From the end of the second week, the cell 
cultures were overgrown by fibroblasts and accordingly the DNA 
content was increasing during the third week of culture (figures 
1 and 2). In contrast, liver extracellular matrix improved the 
attachment and survival of hepatocytes. They lasted for longer 
than 4 to 6 weeks without evidence of fibroblast proliferation 
(figures 1 and 2). In various experiments, hepatocytes could be 
maintained for longer than 3 months. For the freshly prepared he­
patocytes, the beneficial effect of extracellular matrix on the 
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cell attachment was not obvious (figure 2). The nonfrozen hepato-
cytes attached more efficiently onto the plastic dishes than cry-
opreserved cells. Nevertheless, the inhibitory effect of extra-
cellular matrix on the fibroblast proliferation was very evident 
(figure 2). Since extracellular matrix prepared from human liver 
tissue appeared to be superior for the long-term survival of hu-
man hepatocytes than substrata prepared from rat liver or rat 
tail tendon (table 1), for the following studies and because of 
practical reasons, only extracellular matrix prepared from human 
liver tissue was used to compare with the results obtained by 
using plastic as tissue culture substrate. 
as percentage of DNA at T=0 
17 19 21 
day of cul ture 
Fig· 1' The attachment efficiency and survival of cryopreser-
ved human adult hepatocytes in primary cultures on tissue 
culture plastic (· ·) and on plastic precoated with extra-
cellular matrix prepared from human liver tissue (o——o). De-
termination of attachment efficiency and DNA content were as 
described in materials and methods. Each point on the curve 
is the average measurement ±S.D. of at least 5 experiments. 
The increased content of DMA at the last week of experiments 
on plastic was due to fibroblastic proliferation. 
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Fig. 2. The attachment efficiency and survival of freshly pre-
pared human adult hepatocytes in primary cultures on tissue 
culture plastic (· ·) and on plastic precoated with extra­
cellular matrix prepared from human liver tissue (• mi. De­
termination of attachment efficiency and DNA content were as 
described in materials and methods. Each point is the average 
measurement ±S.D. of at least 5 experiments. The increased 
content of DNA at the last week of experiments on plastic was 
due to fibroblastic proliferation. 
RNA synthesis and protein secretion; 
To characterize the effect of extracellular matrix from human li­
ver tissue on the capabilities of human adult hepatocytes in pri­
mary cultures to synthesize RNA and to secrete protein, incorpo­
rations of labelled precursors into RNA and protein were stud­
ied. The incorporation of [б-14С] orotic acid into RNA of 
freshly prepared or cryopreserved hepatocytes in primary cultures 
24 hours after cell seeding, was found at a linear rate for at 
least 20 hours, regardless of the different substrate used (figu­
res 3 and 4). Although the differences were statistically not 
significant, because of the individual variations, in all experi­
ments hepatocytes seeded on extracellular matrix incorporated 
labelled precursor into RNA at a faster rate. 
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[ 6 -1 4C] orotic acid incorporated-
mto total RNA ( DPM per ug DNA) 
1600-
Fig- 3. Incorporation of [6-14C] orotic acid into RNA of 
cryopreserved human adult hepatocytes in primary cultures on 
tissue culture plastic (· ·) and on plastic precoated with 
extracellular matrix prepared from human liver tissue (о—o). 
Each point on the curve is the average measurement ±S.D. of 
at least 5 experiments. 
[6- 1 4 C]orotic acid incorporated into-
total RNA(DPM/ug DNA) 
1400-
1200 
1000 
Fig. 4. Incorporation of [б-14С] orotic acid into RNA of 
freshly prepared human adult hepatocytes in primary cultures 
on tissue culture plastic (· ·) and on plastic precoated 
with extracellular matrix prepared from human liver tissue 
(0 °) · Each point on the curve is the average measurement 
+S.D. of at least 5 experiments. 
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[ 4 , 5 - н ] leucine incorporation mto-
secreted protein (DPM χ 10'3/рд DNA) 
500-
400 
300 
200-
100 
40 48 
time ( hrs) 
^_ _ _ leucine into secreted 
protein of cryopreserved human adult hepatocytes in primary 
cultures on tissue culture plastic (> ») and on plastic 
precoated with extracellular matrix prepared from human liver 
tissue (о—o). Each point on the curve is the average measu­
rement +S.D. of at least 4 experiments. 
Fig. 5. Incorporation of [4-5 3H ] 
[4,5-3H] leucine incorporated into-
secreted protein (0PM χ 10"Уид DNA) 
600 
500 
400 
300-
200 
100 
48 
time (hrs) 
Fig. 6. Incorporation of [4-5 3H] leucine into secreted 
protein of freshly prepared human adult hepatocytes in prima­
ry cultures on tissue culture plastic (· ·) and on plastic 
precoated with extracellular matrix prepared from human liver 
tissue ( о — — o ) . Each point on the curve is the average measu­
rement ±S.D. of at least 4 experiments. 
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The incorporation of [Зн]-1еисіпе into secreted protein was 
also linear for over 30 hours (figures 5 and 6). The secretion 
rate of protein was in concordance with the RNA synthesis also 
slightly higher in cultures of hepatocytes on extracellular ma­
trix than on plastic. 
Albumin secretion and enzyme activities: 
Although the albumin secretion in primary cultures of hepatocytes 
varied and seemed to be dependent on the liver tissue or donor 
from which/whom the hepatocytes were isolated, in all experiments 
the use of extracellular matrix in primary cultures of human he­
patocytes led to a higher rate of albumin secretion than in pri­
mary cultures on plastic dishes. Three representative results are 
shown in figure 7. 
After the first week of culture, the albumin secretion dropped 
gradually and the reduction of albumin secretion was associated 
with enhanced activities of transaminases and lactate dehydroge­
nase in the culture medium. This pattern of changes in albumin 
secretion and enzyme activities in culture medium was observed in 
primary cultures of hepatocytes on plastic as well as on extra­
cellular matrix. However, these changes were delayed for at least 
5 days in primary cultures on extracellular matrix (figures θ and 
9). 
Morphology and fine structures: 
After 12 hours in culture, attached freshly prepared or cryopre-
served hepatocytes after cryopreservation on plastic or on extra­
cellular matrix had formed the confluent monolayer of polygonal 
shaped cells with granular cytoplasm (figure 10). On tissue cul­
ture plastic, attached hepatocytes spread rapidly and after one 
week, cell morphology was less regular and hepatocytes flattened 
with multiple cytoplasmic projections. During the fourth week 
cells detached and died with apparent fibroblast proliferation in 
the culture. These changes were associated with the reduction of 
albumin secretion, enhanced activities of transaminases and lact­
ate dehydrogenase in culture medium and an increased level of DNA 
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content due to the fibroblast proliferation. 
Albumin (pg/pg DNA) 
4 θ 12 16 20 24 28 
culture time (days) 
Fig· 7. The albumin secretion in medium of freshly prepared 
human adult hepatocytes from 3 different liver donors in pri­
mary cultures on tissue culture plastic (·——·) and on plas­
tic precoated with extracellular matrix prepared from human 
liver tissue (о o). 
62 
ALAT 
(mU/>jgDNA) 
280-
240-
200-
160-
120-
^^μ^^Η 
L D H 
(mu/ug DNA) 
-140 
-120 
SO 
6 0 
4 0 
20 
β 10 12 14 16 i e 20 22 24 26 
day of culture 
Fig. 8. The albumin secretion and enzyme activities in medium 
of freshly prepared human adult hepatoc.ytes in primary cultu­
res on tissue culture plastic. Each point on the curves is 
the average value +S.D. of at least 6 experiments. Aspartate 
aminotransferase (ASAT), alanine aminotransferase (ALAT) and 
lactate dehydrogenase (LDH) were determined according to the 
routine clinical laboratory methods. 
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day of culture 
Fig. 9. The albumin secretion and enzyme activities in medium 
of freshly prepared human adult hepatocytes in primary cultu­
res on plastic precoated with extracellular matrix prepared 
from human liver tissue. Each point on the curves is the ave­
rage value ±S.D. of at least 6 experiments. Abbreviations 
used were as described in figure 8. 
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Fig. 10. Light micrographs of cryopreserved human adult hepa-
tocytes in primary cultures on tissue culture plastic (A) and 
on plastic precoated with extracellular matrix prepared from 
human liver tissue (B), 48 hours after cell seeding. Hepato­
cytes were fixed with methanol and stained with Giemsa solu­
tion as described in materials and methods. Hepatocytes had 
formed the confluent monolayer of polygonal shaped cells with 
granular cytoplasm. The nuclei contained prominent nucleoli. 
Magnification: 350x 
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In primary cultures on extracellular matrix (figure 11), hepato-
cytes maintained their cuboidal morphology and typical fine 
structures for at least 2 weeks longer than hepatocytes attached 
to plastic. Mitochondria, glycogen particles, rough and smooth 
endoplasmic reticulum were easy to identify, newly formed bile 
canaliculi with numerous microvilli were reconstituted. Structu­
res similar to tight junctions and desmosomes could also be ob­
served. The classical biliary polarity -the presence of Golgi 
complexes and lysosomes with lipofuscin pigments in the cytoplasm 
near the bile canaliculi- was very evident (figure 12). Despite 
the maintenance of these typical hepatocytic fine structures and 
the absence of fibroblast proliferation in tissue culture, the 
albumin secretion of hepatocytes on extracellular matrix was de­
creased to lower than 4 дд per pg DNA in the fourth week of cul­
ture (figure 9). 
Fig. 11. Transmission electronmicrograph of tissue culture 
plastic precoated with extracellular matrix prepared from 
human liver tissue. Magnification: 4700x 
Ь5 
Fig. 1 
graphs 
cultur 
precoa 
tissue 
Lipofu 
buted 
Struct 
served 
Magni f 
2 (see also opposite page). Transmission electronmicro-
of cryopreserved human adult hepatocytes in primary 
es on tissue culture plastic (A and B) and on plastic 
ted with extracellular matrix prepared from human liver 
(C and D), 10 days after cell seeding. 
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DISCUSSIOH 
Primary cultures of human hepatocytes have been used for studies 
of the liver cells in man (9-17). In our laboratory, we have uti­
lized isolated and primary cultures of human hepatocytes for in 
vitro studies of mutagen activation and drug metabolism (1,3,7) 
and for the study of development and ultrastructural organization 
of liver stages of a specific human malarial parasite: Plasmodium 
falciparum (2,4). From these studies and studies using hepato­
cytes obtained from various animal species, it has become evident 
that marked differences exist between species in the metabolism 
of and susceptibility to drugs, genotoxic agents or parasites. 
Although under certain circumstances human hepatoma cell lines 
could be used, primary cultures of normal human hepatocytes seem 
to be a more attractive approach for studying specific functions 
of the liver cell in man and specific interaction between hepato­
cytes and "liver specific" infectious agents such as hepatitis В 
virus. 
Since the availability of viable tissue for cell isolation is 
very limited and usually unexpected, in a previous paper we have 
presented techniques and adapted the freezing preservation proce­
dure for a long-term storage of viable human hepatocytes (1) to 
create the possibilities for doing we11-programmed experiments. 
Although the results showed that human hepatocytes could be fro­
zen with the maintenance of typical fine structure and specific 
metabolic functions comparable to that of freshly prepared hepa­
tocytes, cryopreservation led to cell loss as the result of a 
10-30% reduction of attachment efficiency and survival of hepato­
cytes seeded on tissue culture plastic (1). In our present study, 
we demonstrate that the deleterious effect of freezing storage on 
attachment and survival of hepatocytes can be significantly abo­
lished by using tissue culture plastic precoated with extracellu­
lar matrix (figure 1). It is also apparent that human hepatocytes 
attach more efficiently to extracellular matrix prepared from 
human liver tissue than from rat liver tissue and rat tail tendon 
(table I). These findings indicate the possible specificity of 
factors (tissue specificity) required for different cells in cul­
ture to attach to a substrate and to survive as previously sug-
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gestea by other investigators (2). In addition, our findings sug-
gest that species specificity of extracellular matrix may also 
play an important role in the cell attachment and survival of he-
patocytes (table 1). The use of extracellular matrix (biomatrix) 
as a cell culture substrate has been propagated for many years. 
It has become evident in recent years that the function of extra-
cellular matrix in tissue culture is not only structural, but 
that it may also influence and maintain specific cellular func-
tions (2). Specific substrates or cellular factors have been 
found to be essential for the maintenance of phenotypic expres-
sion of a specific cell type in vitro. Following culture of hepa-
tocytes on dishes precoated with type I collagen, although the 
cell survival could be prolonged for one or two weeks, hepatocy-
tic functions declined very rapidly (18-20). Rojkind et al. (4), 
however, reported that hepatocytes maintained on rat liver bioma-
trix for at least four months synthesized albumin, conjugated bi-
lirubin and contained phénobarbital activated cytochrome P450 en-
zymes. Using a co-culturing system with rat epithelial cells, 
prolonged maintenance of cell functions and survival of normal 
adult human hepatocytes has also been reported (9). Since cells 
from non-human origin were used, this co-culturing system has 
been subject to criticism in studying specific metabolic func-
tions of human hepatocytes. In this study, we have prepared ex-
tracellular matrix from normal adult human liver according to the 
method as described by Rojkind et al. for rat liver (4). By this 
method of preparation, the extracellular matrix is composed of 
all the known liver collagens (type I, III, IV and V), some gly-
coproteins, fibronectin, glycosaminoglycans, noncollagenous pro-
teins (4 and our own observation) and laminin (our own observa-
tion). As demonstrated in figures 7 and 9 human hepatocytes at-
tached on human liver extracellular matrix synthesize protein and 
albumin (a specific hepatocytic function) at a higher tate than 
hepatocytes attached on tissue culture plastic. Their maintenance 
of typical fine structures was also prolonged (at least 4 weeks 
on human liver extracellular matrix versus 1-2 weeks on tissue 
culture plastic). Increased enzyme activities (transaminases and 
lactate dehydrogenase) in culture medium as observed during the 
second and third week of long-term culture on plastic were also 
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delayed in cultures on extracellular matrix (figures 8 and 9). 
Furthermore, fibroblastic overgrowth was not observed in the 
long-term culture on extracellular matrix. From these findings we 
can therefore conclude that extracellular matrix prepared from 
human liver tissue improves the efficiency of cell attachment of 
human hepatocytes and prolongs the survival and the maintenance 
of typical fine structures and the ability to secrete high levels 
of albumin. This culture condition is especially useful for cryo-
preserved hepatocytes to compensate the cell loss, since the num-
ber of human hepatocytes available is very limited and very valu-
able. Recently, cultivating the liver stages of Plasmodium falci-
parum has also been carried out successfully in our laboratory 
using primary cultures of cryopreserved human hepatocytes on ex-
tracellular matrix prepared from human liver tissue (21). By 
using the cryopreserved hepatocytes and primary cultures on ex-
tracellular matrix, well-scheduled experiments with the necessary 
careful preparations for the investigation of specific hepatocy-
tic functions and specific interaction and development of "liver 
specific" infectious agents in man are, therefore, very feasible 
and can be widely performed. 
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CHAPTER IV 
NUCLEIC ACID PROBE TECHNIQUES FOR THE ROUTINE 
SURGICAL PATHOLOGY LABORATORY 

INTRODUCTION 
The application of molecular genetic, or nucleic acid probe, 
techniques to problems in diagnostic medicine is a continuation of 
a long-term trend to emphasize direct functional evaluation of 
cells in the laboratory. Historically, the first surgical pathology 
and most hematology techniques were based on a pure morphologic 
examination of cells and tissues. This morphologic examination was 
integrated into a scheme of classification of diseases, based on 
the link among populations of sick patients, the course of their 
diseases and the morphology of the lesions. In this model, the 
functional, dynamic behavior of cells is implied in the morphologic 
diagnosis even though this diagnosis of an individual patient's 
lesion is based only on static morphologic cell and tissue 
features. 
Newer techniques in surgical pathology such as enzyme histoche-
mistry and immunopathology are significant steps in the direction 
of functional evaluation of individual patients' diseases. The cell 
properties that these two techniques measure directly, enzyme acti-
vity and antigen expression, are based on cellular synthesis of 
specific proteins. However, since proteins are in fact the last 
link in the DNA-RNA-protein synthetic chain, some of the cell 
properties expressed as protein synthesis and measured by enzyme 
histochemistry or antigen expression may be relatively late and 
only incidental changes in the pathofysiology of lesions. But the 
medianisms at the level of DNA and RNA synthesis which underlie 
this protein expression are only now being explored. He expect that 
patterns of DNA and RNA synthesis may be more closely related to 
the behavior of cells in various disease states than just the 
expression of a normal protein under abnormal circumstances or the 
synthesis of an abnormal protein. 
The nucleic acid probe techniques as applied to cytologic and 
histologic specimens are exactly analogous to the commonly used 
surgical pathology techniques such as routine stains, enzyme histo-
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TARGET PROBE MARKER 
Nonspecific 
Chemical 
Structure by Class 
(Protein, Nucleic Acids) 
Enzyme Activity 
Specific Antigen 
Specific Nucleic Acid 
Segment 
Chemical 
bonding 
Substrate 
Antibody 
Complementary 
Nucleic Acid 
Segment 
Stain 
Insoluble Product 
Radioactive 
Absorbing 
Fluorescent 
Table 1. Comparison of nucleic acid probe technique with stai­
ning techniques, enzyme histochemistry and immunohisto- and cy-
tochemical techniques already in routine use in surgical patho­
logy. The concepts of a "target" in the cell or tissue which is 
"probed" by a specific molecule that either is or has attached 
to it a visible "marker" are the same for all four techniques. 
Therefore, the use of positive ana negative controls, and the 
issues of specificity, sensitivity and preservation of the tar­
get molecule during tissue preparation are the same in the ap­
plication of nucleic acid probe techniques to clinical diagnos­
tic problems as in the use of other well-established target-
probe-marker systems. 
chemistry and immunocytologic techniques (Table I). In immunopatho-
logic techniques, an antigen, usually a protein, is the "target". 
The "probe" is an antibody that, because of the nature of the hu­
moral immune response, is highly specific for a region of protein 
molecule. The "markers" in immunopathology include radioactive tra­
cers, fluorescent molecules (for instance fluorescein, rhodamine), 
and enzymes which mediate reactions resulting in the deposition of 
colored, insoluble reaction products from colorless, soluble pre­
cursors (for instance peroxidase, alkaline phosphatase). 
Using nucleic acid probe techniques, the target is a nucleic acid 
sequence, either a specific gene or gene fragment In DNA or the 
mRNA product of a specific gene. The probe is a labeled segment 
of complementary nucleic acid, either DNA or RNA. The specificity 
of the probe for the desired target nucleic acid sequence is a 
result of the exact matching of Α-T and G-C pairs with one half of 
the pair on the target molecule, the other half on the nucleic acid 
probe molecule. At present, the marker systems in use in nucleic 
acid probe techniques are nearly the same as those used for 
immunopathologic techniques. 
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Results already achieved using molecular genetic definition of dis-
' ease processes indicate that the ability to probe cellular abnorma-
lities at the level of DNA and RNA structure and especially expres-
sion can provide both a more coherent understanding of pathophysi-
ology ana clues to improved patient management. This chapter pre-
sents several examples of practical molecular genetic approaches to 
diagnosis and evaluation of prognosis that are currently applicable 
in routine laboratory medicine. Newer molecular genetic techniques 
that are improving the applicability of these methods in diagnosis 
are discusbed. finally, a practical approach to introducing molecu-
lar genetic methods in a Routine diagnostic laboratory will be pre-
sented. tor recent reviews of these techniques see references 1,2, 
and 3. 
APPLICATIONS 
The basis for all nucleic acid probe, or hybridization, studies 
comes from the fact that DNA in the double helix form can be sepa-
rated into single strands by heat treatment. This is called denatu-
ration. li these single-stranded DNA molecules are prevented from 
reassociating by rapid cooling, it becomes possible to mix single-
stranded DNAs or RNAs from different sources and let them reasso-
ciate or hybridize, provided that the two different molecules have 
enough homologous nucleotide pairs. 
If an unknown DNA target is prepared in such a way that it can hy-
bridize with a labeled known DNA or RNA probe, it is possible to 
detect sequences in the target DNA that have homologies with the 
probe DNA. This probe DNA can be obtained in large amounts by mole-
cular cloning in appropriate bacterial strains. Labeling of the 
probe with the marker can be carried out in many ways and is dis-
cussed later. The target DNA can be obtained from a number of sour-
ces, including serum or other body fluids, cells, and tissues. It 
can be examined in a number of forms, including in situ tissue 
sections, cytologic preparations, or extracted and immobilized on 
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nitrocellulose. 
Using these techniques, it has become possible to detect a wide 
variety of specific DNA and RNA sequences in all kinds of living 
organisms or parts of them. In theory the limiting factor of de­
tecting UNA or RNA will not be the development of sensitive detec­
tion systems but rather the availability of a specific probe. The 
history of hybridization techniques demonstrates a constant 
striving toward optimal circumstances under which hybridization can 
be performed. Sensitivity has been improved, and easier methods 
have been developed to adapt the techniques to routine laboratory 
investigations. There is also a tendency to avoid working with 
radioactive isotopes by labeling DNA with several nonradioactive 
molecules which can be detected in a relatively easy and sensitive 
way. 
HEPATITIS В VIRUS 
The hepatitis В Virus (HBV) represents a major public health pro­
blem. In addition to the mortality and morbidity caused by acute 
infection, over 200 million people worldwide are chronic carriers 
(4). In approximately 90% of cases, HBV causes an acute self-limit-
ing infection that may be either subclinical or symptomatic. Some 
of the infections (5-10%; up to 50% in infants) fail to resolve, 
and these patients become persistent virus carriers. Differentia­
tion between acute infection and the carrier state is of clinical 
and epidemiologic importance (5). Prediction of development of the 
carrier state is presently based on serologic and liver biopsy exa­
mination. 
The HBV virion, or Dane particle, contains DNA as well as a surface 
antigen (HBsAg), an "e" antigen (HBeAg), a viral DNA polymerase and 
a protein kinase. HBsAg, HBcAg and HBeAg can elicit host antibody 
responses, and circulating anti-HBs detected in a patient's serum 
is a good marker for acquired immunity. A high titer of HBsAg in 
serum during the acute phase of Hepatitis B, with persistence for 
more than 6 weeks, is often followed by the development of chronic 
hepatitis (5). Both detectable HBeAg and HBV DNA positivity in 
serum were claimed to be good markers for active virus replication 
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(6). However, the current view is that HBV DNA positivity in the 
serum is a better marker for active virus replication and infec-
tiousness, since some HBsAg and anti-HBe , HBeAg- patients 
have been shown to have active virus replication. Thus active viral 
replication has a strong correlation only with detectable HBV DNA 
m serum, independent of circulating antigens or antibodies (7). As 
a result of these studies, we can no longer rely solely on immuno-
logic markers to identify the status of virus replication or liver 
disease in individuals who have been infected with HBV. 
The assessment of patients following initial HBV infection is fur-
ther complicated by virus genomes that can be present either in the 
cytoplasm of the host cells as free virus or that can integrate in 
the host genome. This distinction of free versus integrated virus 
DNA is clinically important since integration is correlated with an 
increased risk of persistence as well as eventual development of 
hepatocellular carcinoma (8). HBV is a circular genome with a 
length of 3.2 - 3.3 thousand nucleotide pairs (kbp) and has one 
cutting site for the restriction enzyme bcoRl. If total DNA is 
extracted from a piece of liver from an HBV-positive patient, 
treated with restriction enzyme LcoRl, electrophoretically sized, 
blotted on a nitrocellulose filter and hybridized with a 3^P-
labeled HbV probe, only a band of 3.2 kbp will be found in the case 
of free virus. If HBV DNA is integrated and the integrated cell 
population proliferates, bands of other molecular weights may be 
recognizable because the HBV DNA is coupled to the host DNA 
sequences (9). (tig. la). 
In addition to the demonstration of HBV by chemical extraction of 
liver tissue, in situ hybridization (Ibh; see Detection Techniques 
below) can demonstrate viral genome in individual cells in 
histologic sections (12,37,38). (iig. lb). 
Using ISH, distribution of HbV DNA within the tissue as well as 
within individual cells (e.g., nucleus vs. cytoplasm) may be recog-
nized. In addition, a semiquantitative estimation of numbers of in-
fected cells may be gained, tinally, since ISH can be performed on 
formalin-fixed paraffin-embedded tissue, retrospective series can 
be studied, ior example, we found that demonstration of HBV DNA by 
in situ hybridization had a very good correlation with chronic 
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Fig.1 (a) Autoraaiogram of Southern blot of liver UNA from a 
HB&Ag- and HbeAg-positive patient with a hepatocellular carci­
noma. The bisiA was treated with the restriction епгугпез hindlll 
(H) and LcoRl (i,). Kaaioactivity found at 3.2 kilobase and be­
low indicate tree virus and virus replication. Bands of higher 
molecular weight can also be seen, indicating virus DNA inte­
grateci in the host genome, (b) ІЬН of liver section from the 
same patient using biotinylated HbV UNA probes and ABC peroxi-
dast; marker system. Reaction product is seen overlying nuclei 
anu cytoplasm. Bar indicates 10 >ш. (Reprinted with permission 
from American Journal of Pathology). 
hepatitis patients who were known to have had an HBV infection in 
the past (10). These findings were confirmed by other investigators 
(11, 12). 
CHLAMYDIA 
In addition to viruses, other microorganisms may be detected in 
clinical material by nucleic acid probe techniques. Chlamydia 
trachomatis is an obligate intracellular microorganism that has 
GO 
been recognized as the cause of nongonococcal genital infections 
(13,14). Specific and rapid diagnosis of Chlamydia infections is 
important because ot possible complications, especially infertility 
dnd the development of asymptomatic chronic infections in both men 
and women and ectopic pregnancies in women. As a transmissible 
disease, the incidence of Chlamydia infections may exceed that of 
gonococcal infections (15). Asymptomatic infection and silent pro-
gression of the infection are important problems since the infec-
tious agent can easily persist within a population (4). At present, 
the most common diagnostic test for Chlamydia is based on the 
growth oí the microorganibm in continuous epithelial cell lines. 
Ihe lability of the microorganism (17) forms one of the main 
problems in the transport of patient material to the laboratory. In 
audition, the cost of cultunng as primary diagnostic technique is 
high and the diagnosis is slow. Therefore, detection methods which 
are independent of infectious patient material and that are not so 
laborious as the conventional growth methods are being developed. 
These include enzyme-immunoassays ana immunofluorescence methods 
(1£>-2G). Comparison of these techniques with culture reveals a spe-
cificity of 90-95%, while the sensitivity is much lower, 50-70%, 
depending on the specific test (personal communication Dr. K. 
131am, Ьгаытшь University, Rotterdam; see also reference 18). The 
speed with which the diagnosis can be determined using these immu­
nologic methods is 2-5 hours, compared with culture techniques that 
require at least 2-3 days. The cost of direct immunofluorescence/ 
immunoenzymatic techniques is considerably lower m comparison with 
culture. 
The detection of Chlamydia trachomatis DNA directly in clinical ma­
terial by "in situ" hybridization could also be a rapid and supple­
mental method with a high specificity and sensitivity (see also 
fig. ¿) . Preliminciry work in our laboratory lias compared immuno-
logic detection of Chlamydia antigen with a commercially available 
Chlamydia DNA probe (hnzobiochem. New Vork City) labeled with 
either fluorescein or avidin-biotin-peroxidase techniques. Mono-
layers of epithelial cells that are infected in situ with chlamy-
diae show similar sensitivity and specificity of the immunologic 
and ІЛчА probe techniques 72 hours after infection. These findings 
have been confirmed by double-labeling (Fig. 2) techniques and ti-
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Fig.2 Chlamydia infected Hela cells. Coverslip monolayers of 
DEAL· treated Hela 229 cells were inoculated with chlamydia and 
cultured for 72 hours. The coverslips were then stained and 
chlamydial infection was detected first by nucleic acid ISH 
(left) using the ABC system (see also Figure 3). Subsequently, 
the same preparation (right) was examined with immunofluores-
cence for chlamydial infection as described (19). 
Magnification: lOOOx 
tration dilution series. Our initial experience with clinical 
material in the form of cervix smears suggests that in situ DNA 
hybridization is a promising technique with respect to specificity 
and sensitivity compared to the culture technique arid is equally 
sensitive as the immunologic detection of Chlamydia antigens. 
Considerably more work must be done to establish the sensitivity, 
specificity, anc cost-effectiveness of DNA molecular techniques in 
the diagnosis of Chlamydia infections. However, detection of 
cytomcgalovirus-infected cells with a similarity in sensitivity 
between ISH, viral culture and viral antigen detection in frozen 
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sections by monoclonal antibody has also been reported (21). 
CONSTITUTIVE GLNLS 
In addition to the presence and expression of foreign genes, prima-
rily of infectious origin, in human cells, the abnormal expression 
of normal constitutive genes lias proved to be important in a number 
of diseases. An example of the potential clinical utility of this 
area of research is the expression of intermediate filament pro-
teins, specifically the Keratins. 
The intermediate filament proteins (IFP) are elements of the cyto-
skeleton of virtually all human cells. Since IFPs are both highly 
tissue type specific and immunologically distinguishable, immuno-
histo- and cytopathologic examination of tissues to determine the 
presence or absence of specific It'Ps has rapidly assumed a well-
defined role in the surgical pathology of tumors (for review see 
reference 22). 
However, in addition to the continued expression of IFPs normally 
found in cells from which a tumor type originates, some tumors have 
been shown to express IFPs that are not normally present in the 
benign tissue of origin (23,24). Perhaps even more interesting is 
the demonstration that a number of carcinomas express abnormal pat-
terns of IFPs that are normally found in the benign cells of ori-
gin, the keratin proteins. 
For example, in normal bladder epithelium a light (45 kD) acidic 
keratin protein (number 18 according to Moll and associates, ref. 
25; see also ref. 26) is expressed only by the cells of the most 
superficial, luminal, layer. With the development of neoplasia, 
however, increased numbers of cells are found to express keratin 
16, and these cells are no longer limited to the superficial cell 
layers of the epithelium. Further progression of these tumors to 
higher grades and higher states is strictly correlated with 
increasing numbers of tumor cells that express keratin 16 (27). 
At the present time, the mechanisms at the level of UNA and RNA 
that are associated with this abnormal pattern of expression of a 
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normal keratin type are unknown. However, some interesting clues to 
potential clinical use of molecular genetic investigation of this 
phenomenon have already emerged from work in experimental systems. 
The expression of each keratin protein is directly dependent on the 
amount of translatable mRtJA that is specific for that protein in 
the cell (28). Thus, the control of keratin type expression seems 
to take place at the transcriptional level. Several groups have 
demonstrated that control of keratin type expression by cells in 
culture can be influenced by varying the culture conditions (29). 
tor example, human squamous cell carcinomas in culture can be 
induced to differentiate by lowering the concentration of vitamin A 
in the culture medium. This differentiation is expressed both 
morphologically by layering and keratinization and biochemically as 
an increased synthesis of high-molecular weight (67 kD) keratin 
(3G). Conversely, these same investigators have demonstrated 
morphologic dedifferentiation associated with increased synthesis 
of a low-molecular weight (40 kD) keratin protein in the same cell 
line treated with high concentrations of vitamin A. Similar but 
more complex shifts in the pattern of keratin protein expression by 
cultured normal keratinocytes have been induced by infection of 
the cells in culture with SV40 (31). 
Thus, the expression of keratin proteins by cultured cells can be 
manipulated by changes in experimental systems. These manipulations 
produce changes in keratin expression similar to those seen in hu-
man tumors m vivo. Since the regulation of keratin expression is 
at the level of DNA transcription, the application of nucleic acid 
probe techniques to investigate the behavior of the keratin genes 
and their controlling sequences provides information on a cellular 
control system closely linked to the development of neoplasia. 
Active research and initial clinical investigations in many labor-
atories are demonstrating that molecular genetic techniques can be 
clinically important in the diagnosis of other malignant and non-
malignant diseases. These include vimentin expression in tumors 
such as renal cell tumor and thyroid carcinoma and hemoglobino-
pathies such as the thalassemias. 
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DETECTION TECHNIQUES 
KADIOALTlVb MARKERS 
The first applications of nucleic acid probes used RNA or DNA that 
was labeled in vivo by adding ^H Thymidine or 3H Undine to 
stimulated cell lines (32). With the development of advanced mole­
cular biologicdl methods, a cloned DNA or RNA probe was labeled 
with 3H, 3 5S or ^2P by end-labeling or nick translation. 
Briefly, by using the enzymes DNA- or RNA-polymerase, molecules of 
labeled nucleotides can be incorporated into DNA or RNA using one 
of the strands as a template. ^ Ρ incorporated as marker in 
probes has a very high specific activity that results in a high 
sensitivity of the probe. This is necessary for the detection of 
small amounts of target DNA or RNA. However, this marker is very 
unstable, with a Tl/2 of 14 days. 3H-labeled probes are relativly 
stable and produce high spatial resolution, but the energy level 
is too low for rapid detection. 35g
 c a n
 ^
е s e e n a s
 intermediate 
between 3 2P and 3H. 
Liquid Hybridization 
The first hybridizations were performed in aquous solutions. After 
purification of the target DNA, the probe and target DNA hybridize 
with each other, if denatured to single strands before reaction. 
Nonbound probe can be removed by Sl-nuclease, an enzyme that de­
grades single-stranded UNA or RNA. After several washing and fil­
tration steps, the radioactivity, representing the amount of hybri­
dized DNA, can be counted (33). This method yields good quantita­
tive results but is labor intensive. 
Dot-spotting 
Target DNA can also be immobilized in a diluted series on a nitro­
cellulose filter (34). This Is called dot-spotting. Using this 
method, DNA or RNA is purified by enzyme treatment, phenol extrac­
tion and ethanol precipitation, and spotted on nitrocellulose paper 
after denaturation. The immobilized target DNA is then hybridized 
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with a radioactive probe (usually J^P) and can be autoradio-
graphed after several washings. In this way many samples can be 
hybridized simultaneously, and the results, since they are obtained 
from a diluted series, are semiquantitative. This technique can be 
performed on a number of different body fluids, such as serum, 
sputum and urine, and on cell samples. In this procedure the post-
hybridization washing step is particularly important. By raising 
the temperature and lowering the salt concentration of the washing 
solution (stringent washings), only the longest hybrids will remain 
in the hybridized form. In this way the specificity can be im-
proved. The sensitivity level of the dot-spotting technique using a 
"P-labeled probe is approximately 0.2 pg of DNA. The result can 
be obtained within 2 to 4 days. 
Blotting 
By spotting, DNA or RNA in tissue is determined semiquantitatively. 
By analyzing restriction enzyme digests of DNA, it is also possible 
to say something about the state and size of the hybridized target 
DNA. Restriction enzymes have the property of recognizing certain 
nucleic acid sequences and will cut the DNA or RNA at these sequen-
ces. The obtained DNA/RNA fragments of different lengths can be 
sized by electrophoresis on agarose gels. The DNA (35) or RNA (36) 
can be transferred to a nitrocellulose filter and hybridized with a 
labeled probe. In this way, it is possible to conclude in what 
state the detected DNA or RNA is present in the total amount of 
DNA/RNA. For example, it is important to know whether virus genome 
is present in the host cell as free DNA or RNA in the cytoplasm or 
is integrated in the DNA of the host cell. Using blotting techni-
ques, sensitivity of 2 to 5 pg DNA can be achieved. It takes about 
1 week to obtain results. 
In Situ Hybridization (ISH) 
An important problem for routine clinical investigations is that 
the blotting technique requires a considerable amount (more than 20 
mg) of fresh or very well preserved material, for examle snap-
frozen in liquid nitrogen. Another disadvantage of the techniques 
mentioned above is that the extracted DNA/RNA is an average sample 
86 
of the total LNA/KNA. In many situations, only a few cells or a 
certain type of cell contain the target DNA or Ki*A. Also the 
nuclear or cytoplasmic distribution within one cell can differ. 
Iherefore, the need was recognized for a method that made it possi­
ble to detect and localize DNA/RNA in tissue in a form that can be 
observed under a microscope, that is, in situ hybridization (ІЬН). 
It would then be possible to see in which cells the DNA/RNA is 
present and how it is distributed within the cell. 
ISh was first successfully applied to chromosome smears and in 
total nuclei after squashing the tissue (32). The DNA was hybri­
dized with a ^Η-labeled probe, the hybrid covered with a liquid 
photographic emulsion and was autoradiographed. During development 
of techniques for recognizing specific DNA and RNA segments, the 
investigations dealt with the problem that the DNA/RNA in the 
tissue had to be made accessible to the probe and denatured in a 
way that the overall tissue or cell structure was preserved. The 
best results were obtained with frozen sections using J-,£>- and 
3H-labelea probes (12,37,38). One copy of UNA per cell could be 
detected. Blum et al.(39) showed in a very elegant way that ISH has 
its own value beyond immunocytological detection procedures. These 
investigators showed that in liver sections from a Hepatitis-B-posi-
tive patient, HBV DNA was found in different cells from the cells 
that stainea immunologically for the HBcAg and that ground glass 
cells haa in general, neither HBV DNA nor HBcAg (see Hepatitis В 
virus above). 
One disadvantage of the techniques described above is that the 
tissue must be treated in a nonroutine way and that cryostat sec­
tions must be made often from infectious material. Several investi­
gators have been working to improve the method by using formalin-
fixea, paraffin-embedded material (3,10). In this way material was 
no longer infectious and could be handled by standard histologic 
techniques up to and including sectioning. The material can be 
stored at room temperature and retrospective studies can be done on 
stored paraffin blocks. Tissue obtained under nonstenle conditions 
and contaminated tissue can be analyzed. In addition, electron 
microscopic studies have been done, but so far is seems that this 
technique is not sufficiently sensitive or specific for routine 
87 
work (40). 
NONRADIOACTIVE MAKKERS 
Because of the trend to replace radioactive markers (41,42) by non-
radioactive ones that can be more easily handled in routine labora-
tories, newer markers such as fluorochromes and cytochemically 
detectable enzymes have been explored for use in nucleic acid probe 
techniques. These markers also have the advantage of more rapid 
detection, although they are not always as sensitive as radioactive 
markers. Some of these techniques are summarized below. 
The fluorescent dyes TRITC (tetramethyl rhodamine isothiocyanate) 
or FITC (fluorescein isothiocyanate) can be coupled directly to the 
3' end of an RNA chain (43), thus making the probe a fluorescing 
marker analogous to indirect immunofluorescence methods. However, 
since only one fluorescent marker molecule can be coupled to one 
probe molecule, a low "specific activity" is obtained. 
Mercury can be chemically introduced into the pyrimidine ring of 
uridine and cytidine. After hybridization, the mercury can be 
chemically bound to the hapten TNP (Trinitrophenol), which is 
strongly immunogenic and can therefore be detected with fluorescent 
antibodies (44). 
Another hapten that is strongly inununogenic and can be chemically 
attached to guanosine is AAF (2-acetylaminofluorene; ref. 45). 
After hybridization, the AAF-labeled probes are recognized by anti-
bodies directed against AAF-modified guanosine and visualized 
immunocytochemically. 
The use of antibodies to DNA-RNA duplexes has also been introduced. 
In contrast to the other methods described, this method does not 
require chemical or enzymatic modification of the probe. The anti-
genic site of DNA-RNA duplexes probably resides in the sugar-phos-
phate backbone of the target molecule. This implies that the anti-
DNA-RNA antibodies recognize RNA-DNA duplexes independent of the 
base sequence and can be applied in all DNA RNA hybridizations 
(46,47). 
In situ hybridization using a biotinylated probe has been used with 
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Fig.3 Scheme of ISH using a biotinylated probe, (a) Nick trans­
lation of DNA. Pieces of DNA removed by DNAse and repaired by 
DNA polymerase using the complementary strand as a template. 
During repair, biotinylated dUTP is incorporated, (b) Hybridi­
zation. Probe and target DNA are denatured to produce single 
strands and combined to let homologous sequences hybridize. 
(c) Detection of biotin by the ABC system. The biotin of the 
hybridized probe has been coupled to avidin, which with hydro­
gen peroxide and peroxidase can produce a brown precipitate 
from a colorless oxidizable chromogen such as DAB. 
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goou results by a number of investigators (3,10,11,48,49). Using 
nick translation, analogues of dUTP and dCTP containing a biotin 
molecule are incorporated into the probe (fig. 3). The biotin 
molecule can be detected immunologically or enzymatically by ABC 
(Avidin Biotin peroxidase Complex, 50). Figure lb shows a liver 
section of an HBV-positive patient. The peroxidase product can be 
seen in numerous cells, both in the nuclei and the cytoplasm. The 
Southern blot analysis of the bcoRI and Hindlll digested DNA 
extract of the same patient are shown in Figure la. Integrated DNA 
is found as bands above 3.2 kb, the length of the virus, repre-
senting peroxidase products seen in the nuclei by ISH. 
The results of ISh using a biotinylated probe can be obtained 
within 24 hours after preparing the histologic sections. This is 
much faster than autoradiography. However, radioactive probes are 
claimed to be more sensitive than nonradioactive ones. Currently, 
the sensitivity of hybridization using biotinylated probes is 
approaching that of radioactive ones. A sensitivity of 1 pg DNA in 
dot-spotting has been reported (51). 
DISCUSSIOil 
The introduction of nucleic acid probe techniques into a routine 
diagnostic histology laboratory requires definition of both the 
diagnostic problemi s) to be approached and the probe techniques 
most suitable for both the diagnostic problem and the laboratory. 
The technique which currently offers the best specificity with 
adequate sensitivity is restriction enzyme analysis of target DNA 
using blot-hybridization with a 32P-labeled probe. However this 
technique requires staff that is skilled in molecular biology 
methods and special apparatus including facilities for working with 
high-energy radioisotopes. 
The dot-spot hybridization technique is far less laborious and is 
also more sensitive than blotting, but this is at the expense of 
being somewhat less specific. Dot-spotting can give a very good 
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picture of the amount of specific nucleic acid present in clinical 
specimens. This method can be used for large numbers of samples, 
for example, in screening. If high sensitivity is less important, 
the technique can be applied using non radioactive probes, however, 
scaling up the detection level of hybrids by using biotinylated 
probes and detection of probes using fluorochromes with excitation 
at higher Wdvelengths may produce nonradioactive probe-marker sys-
tems with the same sensitivity as is currently achieved only with 
•^P (33). This new direction may eventually completely replace 
32P-labeled probes (52). 
In general, in situ hybridization (ISH) is probably the best 
nucleic acid probe technique for initial routine diagnostic 
applications. Nonradioactive probes can be used, and most of the 
procedure can be performed with equipment that is already available 
in most laboratories. Within the last few years, various commercial 
kits have become available. Nevertheless, the use of good positive 
and negative controls and thorough familiarity with this new 
technique and its microscopic picture are as important as in all 
other surgical pathology techniques. 
False-positive results may initially appear to be a significant 
limitation. For example, detection of the DNA or RNA by the ABC-
peroxidase system may be confused, since these cells may contain 
endogenous biotin or endogenous peroxidase. Special techniques have 
been developed to suppress endogenous avidin binding (53). bndoge-
nous peroxidase activity can be blocked by pretreatment with hydro-
gen peroxide, exactly analogous to the immunologic procedures. In 
addition, cells may contain brown iron or lipofuscin granules that 
can be confused with precipitate. The use of another nonradioactive 
marker could solve these problems, or a parallel hybridization with 
a labeled non-homologous probe in the same tissue could serve as a 
negative control. These examples suggest that further clinical 
applications of nucleic acid probe techniques require the develop-
ment of different kinds of target-probe-marker systems for differ-
ent tissues. Thus, several of the systems with appropriate negative 
and positive controls should be evaluated before starting routine 
investigations. A more serious problem is that hybridization can 
take place with other segments of DNA than intended. For example, 
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probes that were not purified from the plasmid DNA (vector) before 
labeling can cross-hybridize with the plasmid DNA from bacteria 
naturally occurring in the target DNA or tissue. Again, a suitable 
negative control can solve this problem; for example, the hybridi-
zation of the suspected tissue with labeled bacterial DNA. 
The type of material that can be used for nucleic acid probe 
investigations depends primarily on the preservation of the target. 
It several different techniques of preservation are available, one 
has the freedom to choose based on the particular laboratory. 
Material snap-frozen in liquid nitrogen, stored at -70°C, provides 
reasonably good morphologic detail and is a very good method for 
DNA/KNA extraction as well as for 1SH on cryostat sections. The use 
of frozen sections is still the most sensitive technique for ISH. 
The disadvantages of using frozen material are the cost of storage 
facilities and, in the case of virologie research, the continued 
infectivity of the material. Storage in formalin provides excellent 
morphology, but DNA extraction is impossible, and the usefulness of 
the material for ISH declines with time. Material embedded in 
paraffin is easy to store, retains good morphologic detail, and can 
be used for ISH, although ISH on paraffin material is more la-
borious and somewhat less sensitive than ISH on frozen sections. In 
addition, paraffin material is not infectious and provides the 
possibility of doing several examinations in one series of 
sections. 
There remains the problem of interpretation of the findings. In 
some situations, the demonstration of the presence of a specific 
DNA or RNA is immediately important in clinical management. Exam-
ples include demonstration of HBV or Chlamydia, further informa-
tion, however, can be provided by analysis of the state of the DNA 
(e.g., integration of HBV DNA) or the number of gene copies, either 
viral or constitutive. The direct clinical implications of this 
sort of information are still under investigation. Finally, infor-
mation about gene expression, both qualitative and quantitative, 
can only be derived by analysis of mRNA. Again, the clinical con-
sequences of this information must still be defined. 
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CHAPTER V 
ABSENCE OF DETECTABLE HEPATITIS В VIRUS DNA IN 
SERA AND LIVER OF CHIMPANZEES WITH 
попА, nonB HEPATITIS 
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The risk of hepatitis В infections has been reduced by screening of blood donors 
for hepatitis В surface antigen (HBsAg). However, recipients remain at significant 
risk of developing post-transfusion hepatitis. Studies have shown that non-Α, non-
B hepatitis virus(es) are responsible for the majority of post-transfusion hepatitis 
infections. In spite of many efforts, these non-Α, non-B hepatitis viruses have not 
yet been identified. Epidemiological studies, however, suggest that non-Α, non-B 
hepatitis shares many features with hepatitis B. Recently, Wands et al [1982] 
showed, in chimpanzees infected with non-Α, non-B hepatitis agents, the presence 
of antigenemia or viremia by radioimmunoassay with monoclonal antibodies 
directed toward distinct determinants of HBsAg and by molecular hybridization 
analysis. They suggested that non-A, non-B hepatitis agents may be related, but 
distinct variant(s) of hepatitis В virus (HBV). In this study, five chimpanzees were 
inoculated with three different agents that have been shown to transmit non-A, 
non-B hepatitis. The following inocula were used (I) a factor VIII preparation 
kindly provided by D.W. Bradley, (II) acute phase serum from a chimpanzee 
infected with the F strain kindly provided by A.J. Zuckerman, and (HI) a DS-
antigen serum previously shown by us to transmit non-Α, non-B hepatitis [Duer­
meyer et al, 1983]. All chimpanzees developed a rise in transaminase levels 
between 8 and 10 weeks after inoculation. None of the chimpanzees was positive 
for any markers of HBV infection. No evidence was obtained of infection with 
hepatitis A, cytomegalovirus, or Epstein-Barr virus. One chimpanzee developed 
chronic liver disease. The presence of HBV DNA in sera and in liver biopsies 
was studied. HBV DNA hybridizable sequences were not detected in any of the 
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samples collected at different stages of the disease. These findings suggest that the 
non-Α, non-B hepatitis agents in our study are not related to HBV. 
Key words: non-Α, non-B hepatitis; HBV DNA sequence homology 
INTRODUCTION 
The risk of hepatitis В infection has been reduced by routine screening of blood 
donors for hepatitis В surface antigen (HBsAg). However, blood recipients remain at 
significant risk of developing post-transfusion hepatitis [Alter et al, 1978]. In spite of 
many efforts, these non-A, non-B hepatitis viruses have not yet been identified, and 
specific serological tests for antigens and/or antibodies associated with non-A, non-B 
hepatitis are not yet available. Epidemiological studies, however, suggest that post­
transfusion non-A, non-B hepatitis shares many features with hepatitis В with respect 
to the tendency to develop chronic liver disease, the clinical severity, and transmission 
by blood products or close personal contact. Recently, Wands et al [1982] showed, in 
chimpanzees infected with inocula containing non-A, non-B hepatitis agents, the 
presence of antigenemia or viremia by radio-immunoassay with high affinity mono­
clonal antibodies directed toward separate and distinct determinants on HBsAg and 
by molecular hybridization analysis. In contrast Fowler et al [1983] failed to detect 
nucleic acid homology between some non-A, non-B agents and hepatitis В virus 
DNA. The aim of our present study was to evaluate the possible existence of structural 
homology between the nucleic acids of hepatitis В virus (HBV) and non-A, non-B 
hepatitis transmitting agents studied in our laboratories. 
MATERIALS AND METHODS 
Chimpanzees. 
Five chimpanzees in the animal housing facilities of the Organon Scientific 
Development group were inoculated intravenously with the following three different 
inocula, which previously have been shown to transmit non-A, non-B hepatitis: (1) a 
factor VIII preparation, kindly provided by Dr. D.W. Bradley (Centers for Disease 
Control, Atlanta, GA); (2) acute phase serum from a chimpanzee after inoculation 
with F strain, kindly provided by Prof. A.J. Zuckerman (London School of Hygiene 
and Tropical Medicine, London, UK); and (3) a DS-antigen containing serum from a 
patient (K.L.) with hemophilia A, previously shown by us to transmit non-A, non-B 
hepatitis or acute phase serum from a chimpanzee [Oscar] inoculated with serum 
from patient K.L. The infectivity of these inocula is well-documented [Bradley et al, 
1979; Tsiquaye et al, 1980; Duermeyer et al, 1983]. 
Serum of infected chimpanzees was collected three times a week for determi­
nation of liver enzymes. Needle biopsies were performed once every two weeks and 
liver tissue was studied by light microscopy (Prof. G.W. Bras, Pathologisch Instituut, 
Utrecht, Holland) and electron microscopy (EM) (Prof. A.J. Zuckerman, London, 
UK). 
The presence of HBV DNA was studied in sera taken from the chimpanzees at 
times as indicated in Table I. To study HBV DNA in hepatocytes, liver biopsies were 
examined from animals in periods with elevated alanine aminotransferase (ALT) 
levels. 
Assay for Serlologlcal Markers 
Serological marker for hepatitis A [anti-HAV-IgM] or hepatitis В [HBsAg, anti-
HBs, HBeAg, anti-HBe, anti-HBc, and anti-HBc IgM] were tested by enzyme-linked 
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TABLE I. Non-A, Non-B Hepatitis in Five Chimpanzees 
Chimpanzee Strain Sample date* 
ALT 
(U/liter) Histopathologyb EMC 
Serum 
HBV DNA 
Oscar 
Bart 
DS 
DS' 
Andre DS 
Peer FVIII 
Peter 
5 
58 
65 
208 
Preinoculation 
9 
40 
68 
83 
89 
% 
103 
Preinoculation 
62 
73 
336 
463 
665 
Preinoculation 
9 
35 
44 
54 
62 
70 
77 
86 
93 
97 
107 
Preinoculation 
18 
30 
34 
41 
50 
59 
66 
77 
85 
99 
139 
18 
NT1 
70 
13 
23 
27 
33 
31 
30 
30 
38 
36 
26 
40 
63 
27 
33 
21 
22 
30 
33 
37 
46 
31 
50 
90 
49 
23 
21 
19 
22 
26 
38 
41 
43 
39 
68 
113 
37 
16 
16 
25 
-
NT 
+ 
-
-
-
-
NT 
NT 
+ 
NT 
+ 
-
+ 
+ 
+ 
+ 
+ 
-
-
-
NT 
+ 
+ 
+ 
+ 
+ 
NT 
NT 
-
-
NT 
+ 
+ 
+ 
+ 
NT 
+ 
NT 
NT 
NT 
-
-
NT 
+ 
-
-
-
+ 
NT 
NT 
+ 
NT 
+ 
-
+ 
+ 
+ 
+ 
+ 
-
+ 
+ 
NT 
+ 
+ 
+ 
+ 
+ 
NT 
NT 
-
-
NT 
+ 
+ 
+ 
+ 
NT 
+ 
NT 
NT 
NT 
-
"Days after inoculation. 
bA positive sign indicates portal and/or lobular infiltration of inflammatory cells. 
CA positive sign indicates the presence of NANB specific ultrastructural changes. 
dNT, not tested 
'Acute phase seram of chimpanzee OSCAR (day 65) was used as the inoculum in this experiment. 
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immunosorbent assay (ELISA) [Hepanostika, Organon Teknika, Turnhout, Belgium]. 
Infection with Epstein-Barr virus (EBV) was monitored by testing for heterophil 
antibodies (Monosticon, Organon Teknika). IgM-antibodies to cytomegalovirus 
(CMV) were measured by ELISA, similar to the one described for the detection of 
IgM antibodies to Toxoplasma gondii [Duermeyer et al, 1980]. 
Criteria for Non-Α, Non-B Hepatitis [NANB] 
A chimpanzee was considered to be positive for NANB if (1) characteristic 
cytoplasmic alterations were detected in the liver biopsy by EM [Duermeyer et al, 
1983], (2) an inflammatory reaction in the liver was found by histological examination 
or the serum concentration of alanine aminotransferase increased to more than 3.75 
X standard deviation above the mean of the pre-inoculation levels, and (3) other 
possible causes of (viral) hepatitis were excluded by the methods mentioned above. 
Serum HBV DNA Analysis 
The detection of HBV DNA in serum using a molecular hybridization technique 
was performed as described by Berninger et al [1982] with slight modifications. The 
HBV DNA probe consisted of HBV DNA of 3,250-3,300-base pair length, isolated 
by sucrose gradient fractionation of EcoRl restriction enzyme treated plasmid pAOl, 
originally supplied by Dr. J. Summers (The Institute for Cancer Research, Fox Chase 
Cancer Centre, Philadelphia, PA) and kindly obtained from Dr. D.A. Shafritz (Liver 
Research Center, Albert Einstein College of Medicine, New York, NY). Nick trans­
lation was carried out using a modification of the procedure described by Rigby et al 
[1977] with [a32P]dCTP as the labeled nucleotide. The specific activity of the HBV 
DNA translation product was approximately 2 x 108 dpm per ßg DNA. Three 
hundred microliters of serum were used for each determination. After phenol-extrac-
tion of the serum, 350 μΐ of aqueous phase, free of interphase material, was finally 
obtained. Α 100-μΙ sample of this aqueous phase was then used for binding to 
nitrocellulose. The method was able to detect less than 0.5 pg of HBV DNA. 
Liver HBV DNA Analysis 
Liver tissue obtained by biopsy was homogenized in 4-5 volumes of 0.1 M 
NaCl, 0.05 M Tris (pH 7.5), 1 mM EDTA, and 3% p-amino-salicylic acid. DNA 
was extracted twice with 0.5 volume phenol-cresol solution [0.07% (7v) 8-hydroxy-
chinoline, 8% (v/v) fyO, 11% (7v) m-cresol and 81% (v/v) pheno] followed by 
chloroform/isoamyl alcohol (v/v 25:1) extraction at room temperature. DNA was 
precipitated in 70% ethanol. The precipitate was resuspended in 10 mM Tris (pH 
7.5), 1 mM EDTA, treated with RNase, and digested with proteinase К (final 
concentration 100 ¿ig/ml) in the presence of sodium dodecyl sulfate (SDS, final 
concentration 0.5%) followed by a second chloroform extraction and precipitation 
with ethanol. For restriction endonuclease analysis DNA was digested with EcoRl, 
which recognizes one site, and with Hind Ш, which recognizes no sites in the HBV 
genome. Restriction enzymes were purchased from Boehringer Mannheim. Before 
digestion, the DNA was electrophoretically sized to make sure that the sample was 
not degraded. Digestion was carried out under conditions recommended by the 
manufacturer. DNA (30 ^ g per sample) was electrophoresed in 0.5% agarose and 
transferred to nitrocellulose according to Southern [1975]. The filter bound DNA was 
probed with cloned HBV DNA, labelled with 3 2P by nick translation. 
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Hybridization was carried out at 42° С in buffer containing deionized formamide 
(at least 50%), phosphate buffer, Denhardt's solution [Denhardt, 1966], salmon sperm 
DNA, 5 mM EDTA, 5x SSC, after a 2-hr prehybridization (1 X SSC = 0.15 M 
NaCl, 0.15 M Na citrate). After hybridization, the nitrocellulose filter was washed 
thoroughly under stringent conditions as follows: 2 hr at 42°С in the same solution 
as that used for hybridization except the labelled probe; 15 min at 42°С in 2 x SSC, 
0.1 % SDS; and 15 min at 420C in 0.1X SSC, 0.1 % SDS. The filter paper was dried 
and autoradiographed with Lightning-Plus intensifying screens at — 80oC for 1 week 
or longer. 
RESULTS 
Five chimpanzees were successfully infected with non-Α, non-B hepatitis trans­
mitting agents as described in Materials and Methods. This was demonstrated by a 
significant rise of the level of serum alanine aminotransferase (ALT), signs of portal 
and lobular inflammatory infiltrates in the liver, and typical intracytoplasmic changes 
in hepatocytes and sinusoidal lining cells as visualized by EM and published before 
[Duermeyer et al, 1983]. 
Chimpanzee André, inoculated with acute phase serum of chimpanzee Oscar, 
developed chronic non-A, non-B hepatitis (Table I). 
In Table I the values of ALT and the results of microscopical and electronmi-
croscopical examination of the liver are given for the different chimps at the times at 
which serum samples were taken to be studied for the presence of HBV-DNA 
homologous sequences. 
None of the chimpanzees was positive for any marker of HBV infection before 
or after inoculation. Furthermore, no evidence was obtained of infection with hepatitis 
A virus, cytomegalovirus, or Epstein-Barr virus. None of the serum samples obtained 
in the time intervals indicated in Table I was shown to contain material that hybridizes 
to HBV DNA probes. On the other hand, a number of sera from patients with acute 
and chronic hepatitis B, positive for HBeAg, reacted positively in the test (Fig. 1). 
• • • 6 1 6 
2 фф • • • « 7 2 
3 · · · * 8 3 8 
4 9 4 9 
5 10 5 10 
• · · · · # # # · · · 
Fig. 1. Autoradiography by spot technique after hybridization of [32P) HBV DNA to serum extracts. 
Lowest line of both left and right filters: autoradiography of graded dilution of cloned HBV DNA mixed 
with HBV DNA negative serum. Line 1 and line 10 (each consists of four spots) are negative standard. 
Lines 4, 5, and 9 of left filter are HBV DNA negative; lines 2, 3, and 6-8, HBV DNA positive sera in 
graded dilutions with various intensities. These sera were obtained from patients with chronic liver 
disease in the presence or absence of HBV serologic markers. Lines 2-9 of right filter are the 
representative results of sera obtained from chimpanzees after inoculation of non-Α, non-B hepatitis 
agent. 
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Analysis of liver biopsies for HBV DNA homologous sequences was carried out 
before and after digestion with the restriction endonucleases EcoRI and Hind Ш. The 
results are shown in Figure 2. In none of the samples was DNA that hybridizes to 
HBV DNA present. 
DISCUSSION 
It has been suggested that a non-A, non-B hepatitis virus may be a hepatitis В 
virus related virus(es). Trepo et al [1982] proposed that one of the non-A, non-B post­
transfusion hepatitis transmitting agents is related to the HBV group, differing in 
surface antigenicity, but sharing antigens that cross-react with HBesAg and HBcAg. 
Particles resembling hepatitis В Dane particles and filaments have been observed in 
non-A, non-B sera [Trepo et al 1982]. Nucleic acid homology between HBV and non-
A, non-B virus(es) by molecular hybridization studies using [32P]HBV DNA has also 
E H E H E H E H E H E H E H 
if 
1 2 3 Д 5 6 7 
Fig. 2. Autoradiogram of HBV DNA sequences in EcoRI (E) digested and Hind Ш (H) digested DNA 
from PLC/PRF/5 cell line (1), episomal HBV DNA containing liver biopsy specimen obtained from a 
seropositive patient with chronic active hepatitis (7) and from liver biopsies from chimpanzees (OSCAR, 
BART, ANDRE, PEER, and PETER) after inoculation of non-Α, non-B hepatitis agent in periods yrith 
elevated alanine aminotransferase levels (2-6). 
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been reported by Chamay et al [1982] and Wands et al [1982] However, Pnnce et al 
[1982] and Fowler et al [1983] failed to detect such nucleic acid homology between 
HBV and some non-A, non-B virus(es) obtained from sera and from livers of patients 
and experimental animals 
In view of the importance of the problem of non-Α, non-B hepatitis and to 
further evaluate this hypothesis of HBV related non-Α, non-B virus (es), the present 
study was undertaken to investigate the possible existence of structural homology 
between HBV and non-Α, non-B transmitting agents (used in our laboratories). In 
this study, we were unable to detect HBV DNA hybndizable sequences in any of the 
serum samples collected from chimpanzees at different stages of the disease after 
inoculation HBV DNA homologous sequences were also absent in liver biopsies 
taken from these animals in the period with elevated ALT levels These findings 
suggest that the non-A, non-B transmitting agents in our experimental study are not 
related to HBV It is important to note that in our experiments, none of the chimpan­
zees was positive for any serological marker of HBV infection before and after 
inoculation In contrast to our findings. Wands et al [1982] showed the presence of 
antigenemia by radioimmunoassay with high affinity monoclonal antibodies directed 
toward separate and distinct determinants on HBsAg in chimpanzees inoculated with 
non-A, non-B hepatitis transmitting agents However, HBV DNA hybndizable se­
quences were only detected in sera of chimpanzees with high titer antibodies to 
HBsAg from a previous infection with HBV Since examination of liver DNA for 
HBV DNA sequences prior to the inoculation with non-Α, non-B hepatitis virus(es) 
was not performed, the possible liberation during the injury of HBV DNA from the 
liver to the serum has not been ruled out Nevertheless, these contradictory results 
from different laboratories indicate the complex problems of non-A, non-B hepatitis 
Further study of the identity of the non-Α, non-B transmitting agents is required 
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Hepatitis В Virus DNA Detected in Formalin-Fixed 
Liver Specimens and Its Relation to Serologic Markers and 
Histopathologic Features in Chronic Liver Disease 
P. J. M. RIJNTJES. Th. J. M. VAN DITZHUIJSEN. 
A. M. VAN LOON, U J. G. M. VAN HAELST, 
F. a BRONKHOR5T, and S. H. YAP 
To examine the relationship of hepatitis В virus (HBV) 
DNA sequences in the liver with histopathologic features 
and antigenic marken, the authors determined the 
hepatocytic status of viral DNA by in situ hybridization 
in formalin-fixed liver sections using a biotinylated probe 
in 4S patients with various chronic liver diseases. The 
results were compared retrospectively with the HBV sero­
logic markers and histopathologic features including the 
presence of ground-glass cells or Shikata staining posi-
tivity. The specificity of thisin situ detection of HBV DNA 
has been proven excellent in a double-blind control study 
in 18 patients in whom liver HBV DNA was also deter­
mined by DNA extraction, gel electrophoresis, and the 
Southern blotting technique. In 41 patients, the findings 
of HBV DNA and serologic markers were concordant (17 
positive and 24 negative). Twelve of the 20 HBV-
THE HEPATITIS В virus (HBV) is a DNA virus that 
causes a wide spectrum of acute and chronic liver dis­
ease in humans and some nonhuman primates. 
Epidemiologic data indicate that worldwide approxi­
mately 200 million persons are exposed to HBV and 
in the chronic carrier state. ' Chronic carriers of hepati­
tis В virus are at high risk of chronic liver disease and 
are the source of infection. The use of sensitive tests 
to detect HBV antigens and antibodies has enabled us 
to determine various manifestations of HBV infec­
tion.1"* The detection of HBV DNA by its ability to 
hybridize with radioactive or nonradioactive labeled 
DNA prepared from recombinant plasmids containing 
the HBV genome permits a new approach to the un­
derstanding of HBV infection.'"10 Hepatitis В virus se­
quences in liver tissue are usually determined and ana­
lyzed by the technique of DNA extraction from a liver 
specimen, gel electrophoresis. Southern blotting, and 
Fnm iht Dwuton of Cdstromuslina! ani Liver Dueases, Depattmcnl of 
Medicine, Departmenl of Medical Microbiology, and Department of 
fìjthology, St Radboud Unnmtly Hotpttat, Nijmegen, and the 
Department of Pathology, Muntctpúl Hospitaì Arnhem, 
The Netherlands 
DNA-positive patients were HBtAg-posio've (6 with 
chronic hepatitis, 3 with cirrhosis, and 3 with hepatocel-
lular carcinoma). Ground-glass cells or Shikata positiv-
ity were found in 10 of these 12 patients. HBV DNA sé-
quences were found in the Uver of all patients with chronic 
liver disease and serologic positivity for HBV infection. 
In liver with normal histologic feature«, HBV DNA was 
not demonstrable, despite the positive anti-HBc and anti-
HBs. However, a positive HBV DNA was found in 3 sero-
logically negative patients. In another patient the in-
terpretation of findings was impossible because of severe 
hemosiderosis. From this study, it is concluded that in 
situ detection of HBV DNA in formalin-fixed liver sec-
tions has a clinical value and is suitable for routine nee. 
(Am J Pathol 1985, 120:411-418) 
molecular hybridization with radioactive labeled HBV 
DNA probe.'"10 Because of the limitation of this tech-
nique (a significant amount, usually more than 10 mg 
of properly conserved deep-frozen tissue is needed for 
this determination), the method is not suitable for rou-
tine clinical investigation. In this present study, we have 
applied the in situ hybridization technique using bi-
otinylated HBV DNA probe to detect the HBV DNA 
sequences in formalin-fixed liver biopsy specimens of 
Supported in part by a grant from Praeventiefonds. 
A preliminary report of this work has been published in 
abstract form in Hepatology (1984, 4:1018-1048). 
Accepted for publication April 16, 1983. 
Address reprint requests to Dr. S. H. Yap, Division of Gas-
trointestinal and Liver Diseases, Department of Medicine, St. 
Radboud University Hospital, 6500 HB Nijmegen, The 
Netherlands. 
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45 patients with various forms of chronic liver disease. 
The results were compared with the HBV serologic 
markers and with the liver histopathologic features, in­
cluding the presence of ground-glass cells or Shikata 
staining positivity. 
Materials and Methods 
Liver Specimens 
Freshly frozen specimens for the determination of 
HBV DNA sequences by the method of DNA extrac­
tion, gel electrophoresis, and molecular hybridization 
were obtained by percutaneous liver biopsy in 18 pa­
tients referred to our hospital because of chronic liver 
disease. The specimens were stored at -80 С until ana­
lyzed. The formalin-fixed liver specimens for the in situ 
hybridization assay were collected from the same 18 pa­
tients and from an additional 27 patients who under­
went a liver biopsy for routine clinical examination be­
cause of suspicion of chronic liver disease. The biopsies 
were taken between 1 and S years before the present 
study. 
Histologic analysis of liver specimens was performed 
by routine procedures after formalin fixation (4% 
buffered formalin). 
HBV Serologic Markers 
Serologic HBV markers (HBsAg, anti-HBs, anti-
HBc, HBeAg and anli-HBe) were determined by com-
merical enzyme immunoassays or radioimmunoassays 
(AUSZYME-II, AUSAB, CORAB/CORZYME, AB-
BOTT-HBe, Abbott laboratories. North Chicago, III). 
The results of these studies and the histologic findings 
were not made available to the investigator at the time 
of DNA analysis. 
DNA Extraction, Gel Electrophoresis, and 
Molecular Hybridization With "P-HBV DNA Probe 
Specimens of frozen liver tissue were homogenized 
in 4-5 volumes of 0.1 M NaCl, 0.05 M THs HCl, pH 
7.5,1 mM EDTA, and 3% ^-aminosalicylic acid. Total 
nucleic acid was extracted with the use of a 2.5 volume 
of phenol-cresol solution (80% wt/vol phenol, W/tm-
cresol, 9% HjO, and 0.09% 8-hydroxychinolin), fol­
lowed by chloroform and isoamylalcohol (25:i vol/vol) 
at room temperature. DNA was precipitated in 70% eth­
anol at -20 С The precipitate was then resuspended 
in 10 mM TVis HCl, pH 7.5. 1 mM EDTA, and treated 
with RNAse (final concentration, 20 pg/ml) and pro­
teinase К (final concentration, 100 Mg/ml) in the pres­
ence of sodium dodecyl sulfate (SDS) (final concen­
tration, 0.5%). The DNA was reextracted by the 
chloroform-isoamylalcohol mixture and reprecipitated 
with ethanol. For restriction endonuclease analysis, 
DNA was digested with EcoRl, which recognizes one 
site, and with Hind III, which recognizes no sites within 
the HBV genome. Purified DNA restriction en-
donucleases were purchased from Boehringer, Mann­
heim, West Germany. Before digestion, DNA was elec-
trophoretically sized for assurance that the sample was 
not degraded. Digestion conditions were those recom­
mended by the manufacturer. The strategy for restric­
tion enzyme analysis of HBV DNA was as described 
by Shafritz and Kew.' The final DNA (20 μ§ per sam­
ple) was disolved in buffer (40 mM Tris HCl, pH 7.8, 
10 mM EDTA, 10% glycerol, 0.5% SDS, and 0.2% 
agarose) was incubated at 45 С for 2 minutes and ap­
plied to the 0.5% agarose gel. 
Electrophoresis was performed with the gel sub­
merged in 40 mM THs HCl, pH 7.8, 50 mM sodium 
acetate, 1 mM EDTA at 30 volts for 40-48 hours. DNA 
was transferred to 0.45-μ nitrocellulose filter sheets 
(Schleicher & Schuil, Dassel, West Germany) accord­
ing to the procedure of Southern." The filters were 
dried, baked in a vacuum oven at 80 С for 2 hours and 
hybridized with cloned HBV DNA labeled with " P to 
a specific activity of 3-4 χ 10* cpm/^g by the method 
of Rigby et a l ." 
The HBV DNA probe used for this study was purified 
HBV DNA of 3250 to 3300 base pair length, isolated 
by agarose gel electrophoresis of EcoRl restriction 
enzyme-treated plasmid pAOI-HBV, originally supplied 
by Dr. J. Summers (The Institute for Cancer Research, 
Fox Chase Cancer Center, Philadelphia, Pa) and kindly 
obtained from Dr. D. A. Shafritz (Liver Research Cen­
ter, Albert Einstein College of Medicine, New York, 
NY). 
Hybridization was carried out at 42 С in a buffer so­
lution containing deionized formamide (50%), 20 mM 
phosphate buffer (pH 6.8), Denhardt's solution (0.02% 
bovine serum albumin, 0.02% polyvinylpyrolidone, 
0.02% Ficoll 400), salmon sperm DNA (0.1 mg/ml), 
5 mM EDTA, 5 χ SSC (1 χ SSC: 0.15 mM NaCl, 0.015 
mM Na-acetate) after a 2-hour prehybridization in the 
absence of HBV DNA probe. The nitrocellulose filter 
was then washed thoroughly under stringent conditions 
as follows: 2 hours at 42 С in the hybridization mixture 
without the probe, 15 minutes at 42 С in 2 x SSC and 
0.1% SDS, and 15 minute at 42 С in 0.2 χ SSC and 
0.1% SDS. The filter paper was dried and autoradio-
graphed with Lighting-Plus intensifying screens at 
-80 С on Kodak XAR-2 film for at least 1 week. 
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In Situ Hybridization of Formalin-Fixed Liver 
Specimens With Biotinylated HBV DNA Probe 
Liver specimens were fixed as for routine histologic 
analysis in 4% buffered formalin and embedded in 
paraffin blocks Five-micron-thick sections were floated 
on a solution containing 0 Sfo (wt/vol) gelatin, 0 05% 
(wt/vol) chromalum, and 0 02% sodium azide and 
stretched on slides which had been previously cleaned 
with ethanol The slides were then baked overnight at 
60 С This procedure was necessary to prevent the tis­
sue sections getting off during hybridization assay The 
sections were dewaxed by two lO-minute incubations 
in xylene and placed for another 10 minutes in metha­
nol containing 1 0% (vol/vol) H2O2 for inactivation of 
endogenous peroxidase activity and for removal of re­
sidual formalin crystals After washing in absolute eth­
anol for 10 minutes, the sections were hydrated by se-
questial 5-minute incubations in ethanol-Η,Ο mixture 
containing 95%, 80%, 60%, 30%, and 0% ethanol, 
respectively The slides were then treated with proteinase 
К (Merck, Darmstadt, West Germany) in a solution con­
taining 0 01 mg proteinase K/ml, 20 mM Tris HCl, pH 
7 4, 2 mM CaClj and incubated in a humid chamber 
at 37 С for 15 minutes After washings in phosphate-
bu ffered saline solution (PBS 0 13 M NaCl, 0 01 M so­
dium phosphate, pH 7 4) containing 0 2% glycin for 
stopping proteinase К activity, the slides were sub­
merged in PBS containing 4% paraformaldehyde to 
stabilize the DNA as reported by Haase et al " The 
residual paraformaldehyde was removed by washings 
in PBS containing 0 2% glycine The slides were then 
dehydrated through a graded ethanol-H20 series con­
taining 50%, 70%, 80%, 90%, and 100% ethanol and 
air-dried Hybridization was carried out with cloned 
HBV DNA as described previously, but labeled with 
biotin For this labeling, the dTTP was replaced by an 
equimolar Bio-I 1-dUTP (ENZO, Biochem, New York, 
NY) in the nick translation assay as described by Rigby 
et al , 2 In order to estimate the incorporation of B10-
dUTP in the nick translation product, a small amount 
of 3H-dATP was added to a final activity of 3 5 χ 10* 
cpm/Vmol Nick translations were regarded as optimum 
1 f incorporation of more than 50% of the ^-dATP was 
obtained Unincorporated nucleotides were removed by 
Sephadex G50 column chromatography The labeled 
DNA probe was devided in aliquots and stored at - 20 
С until use 
Air-dried sections were hybridized in medium con­
taining 50% (vol/vol) deionized formamide (Baker, 
Phillipsburg), 10% wt/vol dextran sulfate (Pharmacia 
Fine Chemicals), 3 χ SSC buffer, pH 7 0, 800 Mg/ml 
sonicated carrier DNA (Herring Sperm, Boehrmger 
Mannheim, West Germany) and 2 pg/ml of biotin-
labeled probe DNA which were previously denatured 
at 100 С for 3 minutes in an equal volume of forma-
mide and quick cooled on ice. Each tissue section was 
overlaid with 10 pi of the hybridization mixture and cov­
ered with a coverglass The slides were then transferred 
to a stainless steel humid chamber which was covered 
inside with filter pads, soaked in formamide buffer 
(50% vol/vol foramide and 3 χ SSC, pH 7 0). Under 
these circumstances, it was not necessary to seal the 
coverslips The humid chamber was incubated at 80 С 
for 5 minutes for denaturing the DNA and then over­
night at 37 С 
After hybridization in the slides were immersed in 
2 χ SSC, and the coverslips were removed and washed 
for 3 minutes at 32 С and in PBS containing 0 1% 
(vol/vol) Triton-X (BDH, Poole, U К ) for another 3 
minutes and finally in PBS for 3 minutes In a humid 
chamber at 37 C, the slides were covered with 200 μΐ 
of the 1 250 diluted streptavidin-biotm-horseradish 
peroxidase complex (ENZO, Biochem) m PBS contain­
ing 1% (wt/vol) bovine serum albumin for 30 minutes 
as described by the manufacturer The slides were 
washed in freshly prepared PBS containing 0 1 % 
(vol/vol) Triton-X for 3 minutes and twice for 3 minutes 
in PBS and were developed with the use of a freshly 
prepared PBS mixture containing 0 5 mg/ml di-
aminobenzidine tetrachloride (Sigma, St Louis, Mo) 
and 0 01% Н2Од for 20 minutes at room temperature. 
The reaction was then stopped by washing with PBS 
The slides were counterstained with 0 25% (wt/vol) 
methyl green (Merck, Darmstadt, West Germany) in 
0 03 M sodium acetate, pH 4 8, for 2 minutes, washed 
for 2 minutes in 0 03 M sodium acetate, pH 4 8, and 
air-dried After a dehydration in aceton-xylene (1 1 
vol/vol) for I minute and xylene alone for 3 minutes, 
the slides were mounted 
Results 
The specificity and the sensitivity of m situ hybridi­
zation for detection of HBV DNA sequences in liver 
sections were examined in 18 patients by comparing the 
results with the findings as determined by the method 
of DNA extraction and gel electrophoresis (Table 1) 
Each in situ hybridization assay was considered valid 
only if control sections were found to contain the ex­
pected grain density A known positive section con­
tained positive cells with 10-40 grams, and a known 
negative section showed a background of less than 2 
grains per cell (Figures 1-3) In 7 patients in whom HBV 
DNA sequences were detected by DNA extraction, gel 
electrophoresis, and Southern blotting, HBV DNA se-
1 1 1 
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Table 1 - i n S((u Hybridization Versus Soulhern Blotting 
Technique in Detection of H B V D N A in 18 Patients With 
Chronic Liver Disease 
H S V D N A as 
detected by 
Serologic markers 
Hybridi­
zation 
+ 
_ 
+ 
-
blotting 
technique 
+ 
+ 
-
-
No of 
patients 
7 
l 
2 
β 
HBsAg·/ 
antiHBs· 
4/1 
1/0 
0/? 
0/3 
HBeAg·/ 
antiHBe 
3/1 
1/0 
0/0 
0/0 
antiHBe· 
7 
1 
2 
3 
quences were also found in formalin-fixed liver sections 
as demonstrated by in situ hybridization (Table 1). Free 
and or integrated HBV DNA detected by in situ hybridi­
zation technique in this study was predominantly 
cytoplasmic as shown in Figure 1. The positive cells 
were focally distributed with variable DNA content of 
different positive cells in the section. Eight patients with 
a negative finding in the in situ hybridization assay also 
had no detectable HBV DNA as determined by the other 
technique. However, 1 patient was found positive for 
episomal viral DNA by the blotting technique, but no 
HBV DNA was demonstrable in the m situ hybridiza­
tion assay. This patient was suffering from HBsAg- and 
HBeAg-positive chronic active hepatitis. In 2 other pa­
tients, HBV DNA was found in small spots in the in 
situ hybridization assay, despite the negative finding in 
the blotting technique. These 2 patients were anti-HBs-
and anti-HBc-positive, and both had hepatocellular 
carcinoma. 
To further investigate the possible false positivity 
of this technique for detection of HBV DNA, we 
have reexamined the liver sections with the positive 
findings using DNA probe derived from plasmid DNA 
containing cytomegalovirus. In this control experiment, 
no grains were found in the liver sections, which indi­
cated that there is no nonspecific positive result with 
streptavidin-biotin-horseradish peroxidase complex in 
these HBV-DNA-positive patients. After this encourag­
ing result concerning the sensitivity and the specificity, 
the clinical significance of this in situ hybridization of 
HBV DNA detection in formalin-fixed liver biopsies was 
investigated in 45 patients with various liver diseases. 
These liver specimens were obtained as paraffin-em­
bedded sections for routine clinical investigation. The 
results were compared with HBV serologic markers and 
histopathologic features, including the presence of 
ground-glass cells or Shikata staining positivity. The 
histologic findings and serologic data of the 45 patients 
7.5-
5.9-
4.8-
3Λ-
Figure 1 -Detection of HBV DNA se­
quences in liver by the methods of DNA 
excretion, get electrophoresis, and 
Southern blotting (left) and by in situ 
hybridization in a section of formalin-
fixed, paraffin-embedded liver {nght ob­
tained from a patient with HBsAg/ 
HBeAg-positive hepatocellular carcino­
ma Endonucleases ECORi (lane E) 
and HIND III (lane H) digested DNA was 
fractionated on 0 5% agarose gel and 
transferred to nitrocellulose paper and 
hybridized with nP-labe(ed HBV DNA 
probe as described in Materials and 
Methods The autoradiogram shows 
the presence of integrated (distinct 
bands in high-molecular-weight 
regions) as well as free or episomal 
HSV DNA sequences (diffuse hybridi­
zation pattern in regions below 3 4 kilo 
base pairs) In Irver section. HSV DNA 
sequences were detected by an m situ 
hybridization technique using a bi-
otmylated HBV DNA probe (nght) A 
field showing hepatocytes with positive. 
mainly cytoplasmic grains Nuclear 
localization of grains {arrow) ts also 
seen m this figure In original picture 
hepatocytes were stained green, and 
the grams were brown (bar » 10 μ) 
1 1 2 
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Figure 2-Detection of HBV 
DNA sequences in liver by the 
methods of DNA extraction, gel 
electrophroesis, and Southern 
blotting {left) and by in situ 
hybridization in a section of 
tormalin-fixed paraffin-em­
bedded liver (ngh!) obtained 
from a patient with non-B 
chronic hepatitis The hybridi­
zation methods and the labeled 
HBV DNA probes used were as 
described in Figure 1 No HBV 
DNA sequences were detected 
in this liver by both methods A 
field showing grains with a den­
sity lower than 1-2 grams per 
cell (bar = 10 μ)-
7 . 5 — 
5 . 9 — 
3Λ— 
xr 
are given in Table 2. The patients were 25 males and 
20 females ranging in age from 11 to 78 years. Twelve 
patients were serologically positive for HBsAg. Eight 
patients who were serologically negative for HBsAg 
were anti-HBC-positive. Three of these 8 patients were 
anti-HBs-negative. In 20 patients with markers of HBV 
infection, histologic evaluation of the liver revealed 
chronic persistent hepatitis in 4, chronic active hepati­
tis in 4, cirrhosis in 4, hepatocellular carcinoma in 5, 
and histologically normal liver in 3. Fifteen of these 
patients were male. 
Among the 25 patients without evidence of HBV in­
fection as demonstrated by the absence of HBV sero­
logic markers were 15 females and 10 males. Five pa-
Flgure 3-Detectran of HBV DNA se­
quences in an Alexander (PLC/PRF 5) 
hepatoma cell line by the'in sttu hybridi­
zation technique using a biotinylated 
HBV DNA probe Cells were fixed in 
4ÛA buttered tormalm A field showing 
cells with predominantly nuclear locali-
zation of grains This PLC/PRF 5 hepa-
toma cell line is known to contain only 
integrated HBV DNA in the cell genome 
(bar - 10 μ). 
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Table 2—Histologic Fir.dings of 45 Patients With 
Chronic Liver Disease 
A Patients with positive HBV mar 
Histologic 
study 
HCC 
Cirr 
CPH 
САН 
Normal 
Total 
Antl-
HBC· 
5 
4 
4 
4 
3 
20 
HBsAg* 
3 
3 
4 
2 
0 
12 
kers 
Anti 
HBs· 
2 
0 
0 
1 
2 
5 
HBeAg-
2 
2 
3 
2 
0 
9 
Antl-
HBe· 
0 
1 
0 
0 
0 
1 
В Patients without HBV markers 
Histologic 
study 
HCC 
Cirr 
CPH 
САН 
Normal 
Total 
Number 
3 
5 
5 
12 
0 
25 
HCC hepatocellular carcinoma Cirr cirrhosis CPH chronic persistent 
hepatitis САН chronic active hepatitis 
tients had chronic persistent hepatitis, and 12 patients 
had chronic active hepatitis Cirrhosis was found in 5 
and hepatocellular carcinoma in 3 patients In none of 
these patients was chronic alcohol liver disease or pri­
mary biliary cirrhosis suspected 
In 41 patients (Table 3), the findings of HBV DNA 
and serologic markers were concordant (17 positive and 
24 negative) "I\velve of the 20 HBV-DNA-positive pa 
tients were HBsAg positive (6 chronic hepatitis, 3 cir­
rhosis, and 3 hepatocellular carcinoma) Ground-glass 
cells or Shikata staining positivity were found in 10 of 
these 12 patients Three patients with HBV-DNA-posi-
tive and HBsAg negative but anti-HBc-positive (1 of 
these patients was also anti-HBs-posilive) were proven 
to have integrated HBV DNA as determined by DNA 
extraction, gel electrophoresis, and restriction en-
donuclease analysis (data not shown) From the 24 pa­
tients without detectable HBV DNA, 21 patients had 
no serologic markers of HBV infection, 3 patients were 
anti-HBc-positive, and 2 of these 3 patients were anti-
HBs-positive. In this study we also demonstrated a posi­
tive HBV DNA in three serologically negative patients 
In 1 patient, the interpretation of the finding was not 
possible because of severe hemosiderosis 
Discussion 
In transmission of HBV in humans and chimpan­
zees, it has been demonstrated that the individuals con­
taminated with the infectious agents may develop acute 
hepatitis " " " In natural transmission, however, initial 
infection is often subclinical or unrecognized After 
acute infection, some individuals become chronic ear­
ners with or without liver sequelae. For the pathogene­
sis of chronic liver disease after HBV infection, im­
munologic and fibroplastic processes have been 
incriminated Lymphocytotoxicity with or without con­
tribution of antibodies has also been thought to be 
responsible for the persistence of liver-cell necrosis. 
However, factors influencing the chromcily of inflam­
matory reaction m the liver, the persistence of HBV 
replication and the development of chronic liver dis­
ease, including hepatocellular carcinoma, have not yet 
been clearly elucidated The widespread use of sero­
logic markers of HBV infection, liver biopsy, and de­
terminations of serum aminotransferases has enabled 
us to determine acute infection and chronic carrier or 
infection in the past and to recognize histologic changes 
which may be associated with the progression to cir­
rhosis With the advent of newer techniques in molecu­
lar biology, highly sensitive methods have been devel­
oped to detect HBV DNA sequences in the liver cells ' * 
In tumors of HBsAg-positive patients with hepatocel­
lular carcinoma, HBV DNA sequences were found to 
be integrated in the host genome.' " Based on this 
finding and its analogy to viral carcinogens in general, 
it has been suggested that integration of HBV DNA into 
the human genome occurs in conjunction with malig­
nant transformation " " Nevertheless, integrated HBV 
DNA has also been found by us (data not shown) and 
Table Э-НВ DNA Status as Detected by In Situ Hybridization and HBV Serologic Markers In 45 Patients 
With Chronic Liver Disease 
No ol 
patients 
12 
5 
3 
3 
21 
1 
HBsAg a 
+ 
-
-
-
-
-
nti-HBc 
Ground-glass cells/ 
Shikata staining 
positivity HBV DNA Histologic study 
3 HCC 3 Cirr 6 CPH or САН 
5 CPH or САН 
Normal 
3 CPH or САН 
S HCC e cirr 10 CPH or САН 
CPH severe hemosiderosis 
HCC hepatocellular ceremonia Cm cirrhosis CPH chrome persistent hepatitis САН chronic active hepatitis 
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by others710 in patients with various forms of chronic 
liver disease without evidence of hepatocellular carci­
noma. Because the exact mechanisms for the develop­
ment of chronic sequelae in the liver as the result of 
HBV infection are still not known, questions have arisen 
concerning the relationship of HBV DNA to the oc­
currence, extent, and persistence of viral replication, 
to the expression of antigenic markers, to a specific im­
mune defect, and to HBV-associated carcinogenesis. To 
answer these questions, molecular biologic studies in 
conjunction with morphologic investigations are neces­
sary. The determination of the intrahepatocytic status 
of HBV DNA sequences by DNA extraction, gel elec­
trophoresis, and transfer to nitrocellulose filter sheets 
had a limited clinical applicability because it requires 
a significant amount of properly conserved liver speci­
mens. In addition, a positive finding detected by this 
technique would only reflect the average status of HBV 
DNA in total DNA extract contributed by HBV-
DNA-positive and -negative hepatocytes,. fibroblasts, 
and stroma cells. The ability to use the in situ hybridi­
zation technique in order to characterize HBV DNA 
sequences in individual cells and in conjunction with 
the histologic findings gives a new dimension to our 
effort to understand the pathobiology of HBV infec­
tion and persistence. 
The major difficulty in the in situ hybridization 
method is the requirement that target molecules must 
be retained in a suitable state for hybridization while 
avoiding artefacts. Another limiting factor is the min­
ute quantities of DNA or RNA in the cell and the steric 
hindrance produced by external and internal cell bound­
aries. As shown in this study, we have overcome these 
difficulties and utilized a biotinylated probe and in situ 
hybridization in formalin-fixed and paraffin-embedded 
tissue sections to study the intrahepatocytic status of 
HBV DNA sequences. The in situ hybridization to de­
tect viral sequences was described originally by Brahic 
and Haase™ using Ή-labeled probes which take 10-40 
days in developing the grains. Although this handicap 
has recently been overcome with the use of "S-labeled 
probes,21 the relatively short functional half-half of ra­
dioisotope, personnel safety, and the isotope disposal 
problems make it desirable to have alternatives. The in­
troduction of enzymatic synthesis of biotin-labeled 
polynucleotides by Langer et al" permits the new ap­
proach of labeling DNA probe and the development 
of rapid, sensitive, and specific diagnostic tests for vi­
ral infection such as cytomegalovirus." In this study 
we have applied the same technique to detect HBV DNA 
sequences in liver biopsy specimens. This technique of 
HBV DNA detection in liver sections does not require 
fresh-frozen tissue. In addition, the HBV DNA probe 
is labeled with a nonradioactive marker and can be 
stored for a longer period; it is therefore very suitable 
for routine investigation. The total procedure can be 
performed within 24 hours, and numerous samples can 
be processed simultaneously. Although a comparative 
study on the sensitivity for detecting HBV DNA se­
quences in in situ hybridization assay using a biotin or 
radioisotope labeled probe has not yet been performed 
in our study, an excellent specificity was found when 
the results of this technique using a biotinylated probe 
were compared with those of DNA extraction, gel elec­
trophoresis, and Southern blotting in liver biopsies of 
18 patients. Three patients with only integrated HBV 
DNA whose serum was HBsAg-negative but anti-
HBc-positive were also positive for HBV DNA as de­
tected by the in situ hybridization. A false-negative re­
sult was found in 1 patient. This negative finding in an 
HBsAg- and HbeAg-positive patient was probably due 
to a sampling error rather than to the insensitivity of 
this technique, since 2 other patients with negative 
finding in blot hybridization were found to be positive 
by the in situ hybridization method (Table 1). In an­
other patient, the interpretation of findings was impos­
sible because of hemosiderosis. Although the current 
results are encouraging, it is still at this moment not 
possible using this technique as to distinguish between 
the presence of chromosomal and of episomal DNA. 
In patients with integrated HBV DNA, grains were 
found not only in the nucleus, but also in the cytoplasm 
of the cells as in other patients who were positive only 
for episomal HBV DNA. This finding may be due to 
the formation of DNA-DNA and DNA-RNA hybrids. 
In the present study, it is important to note that HBV 
DNA sequences were found in the liver of all patients 
with chronic liver disease and serologically positive for 
HBV infeciton. In histologically normal liver, however, 
HBV DNA was not demonstrable, despite the positive 
antiHBc and antiHBs. Furthermore, HBV DNA se­
quences were also detected in 3 patients with chronic 
hepatitis without any serologic markers of previous 
HBV infection. In view of the stringency of assay con­
dition and of the specificity of the method as demon­
strated in the control study, the positive finding in these 
3 particular patients must be considered to indicate the 
presence of HBV DNA sequences in the liver. The posi­
tive finding of HBV DNA in livers of some patients with 
a negative serologic marker for HBV infection has also 
been reported by other investigators using the blot 
hybridization method." Although the existence of 
structural homology of nucleic acids between HBV and 
some types of non-Α, non-B transmitting agents is pos­
sible, as suggested by Wands et al," the clinical 
significance of our finding in these 3 patients is not yet 
clear at this moment. Further studies remain to be es­
tablished. From the foregoing results, however, we can 
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conclude that in situ detection of HBV DNA in 
formalin-fixed liver sections has a clinical value and is 
suitable for routine use. 
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CHAPTER VII 
IN VITRO INFECTION OF PRIMARY CULTURES OF 
AtfULT HUMAN HEPATOCYTES ΪίΙΤΗ 
HEPATITIS В VIRUS 

ABSTRACT. Infection with HBeAg and HBV DNA positive serum in 
primary cultures of human hepatocytes in the presence of hu­
man whole blood in the medium was performed in θ consecutive 
experiments. HBsAg and HBV DNA release into the medium was 
increased in the second week after infection. Via immunostai-
ning HBcAg was first observed in the nucleus of hepatocytes 
approximately 3 days after infection. A maximal percentage of 
HBcAg positive cells in 0.1% of cultured hepatocytes was 
detected on the 7th day. HBsAg was first demonstrated also on 
the 3rd day and predominantly localized in the cytoplasm. 
About 5% of hepatocytes was HBsAg positive on the 12th day 
after infection. The percentage of positive cells did not 
appear to increase after this time. Using in situ cytohybri-
dization and agarose gel electrophoresis and Southern blot 
analysis, HBV DNA was first detected on the 4th day. In addi­
tion, electron microscopic studies revealed the presence of 
42 nm virus like particles in the cytoplasm of infected cells 
in the second week after infection. This in vitro system pro­
vides a model for studying the mechanism of HBV infection, 
viral replication and maturation. However, further improve­
ment of culture systems is needed to increase the number of 
infected cells and for active HBV replication. 
INTRODÖCTIOH 
Hepatitis В is a great public health problem in the world (1). 
Despite the major advances in hepatitis В research, and the deve­
lopment of effective vaccines for prevention of hepatitis В virus 
(HBV) infection (2), major gaps still exist in our knowledge of 
the pathobiology of hepatitis В virus and the molecular and cel­
lular basis of acute and chronic liver disease due to HBV infec­
tion (3). Consequently the soil from which new therapeutic stra­
tegies must grow has remain barren. Studies of the mechanism of 
initiation of infection, viral replication and of the pathogene­
sis of hepatocellular necrosis seen in acute and chronic HBV in­
fection in man have been hampered by the lack of appropriate and 
well characterized specific in vivo (animal) or in vitro models. 
A permissive and reproducible cell culture system to propagate 
HBV is not yet available. 
In our laboratory, we have utilized isolated and primary cultures 
of human hepatocytes for in vitro studies of mutagen activation 
and drug metabolism (4-6) and for the study of development and 
ultrastructural organization of liver stages of a specific human 
malarial parasite: Plasmodium falciparum (7-8). Studies in vitro 
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using human hepatocytes are, however, still scarce, mainly due to 
the limited availability of viable tissue and the lack of suita­
ble methods for preservation and storage when the viable hepato­
cytes are available. In a previous paper (9), we have demonstra­
ted that living normal human hepatocytes can be stored for a long 
period of time by cryopreservation. After thawing, these cells 
seeded on extracellular biomatrix prepared from human liver tis­
sue could survive and maintain their typical phenotypic expres­
sion for 3-4 weeXs. Although cultivating the liver stages of 
Plasmodium falciparum in Hep G2, a well differentiated human 
hepatoma cell line (10), did not result in development of this 
parasite, cultivating has been successfully carried out using 
these primary cultures of cryopreserved human hepatocytes on ex­
tracellular biomatrix (12). 
In the present paper, we report that these primary cultures of 
human hepatocytes are proved as a reproducible and efficient sys­
tem for infecting cells in vitro with hepatitis В virus. 
MATERIALS AHD METHODS 
Materials: 
Collagenase type I, bovine serum albumin, 4-(2-hydroxyethyl)-l-
piperazine ethanesulfonie acid (Hepes) and TES (2-[2-Hydroxy, 
1,1-bis (hydroxy-methyl) ethyl] amino ethane sulfonic acid) were 
purchased from Sigma. William β medium E and fetal calf serum 
were from Flow Laboratories. Triton X-100 and sodium dodecyl-sul-
fate were obtained from BDH Chemicals Ltd. EGTA (ethylene glycol-
bis (Camino ethyl ether) N, N, N1 , N* -tetra acetic acid), EDTA 
(ethylene di amino tetra-acetic acid), phenol, sodium deoxychola-
te, salts and solvents were purchased from E. Merck. Dexametha-
sone disodium phosphate (Oradexon1*), was obtained from Organon, 
The Netherlands. 
Chemicals, unless otherwise specified, were of analytical purity. 
All glassware was sterilized and solutions were freshly prepared 
and autoclaved prior to use. 
All solutions used in the hepatocyte isolation and culturing, 
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were filtered through a 0.22 μη Millipore filter and stored fro­
zen. 
Preparation of isolated hepatocytes: 
Post mortem human liver tissues were obtained from kidney donors. 
Hepatocytes were isolated by a two-step perfusion technique modi­
fied as described previously (9). 
Deep freezing storage of hepatocytes; 
The isolated hepatocytes were suspended in ice cold William's 
medium E containing 10% (v/v) dimethylsulfoxide (DMSO) and 20% 
(v/v) fetal calf serum in a density of 5 to 15 χ IO6 viable 
cells per ml. Freezing was performed in storage vials (NUNC) 
using a Cryoson BV-4 programmable freezer. Cooling was obtained 
by computer controlled liquid nitrogen evaporation. After an 
equilibration (5 minutes) at a starting temperature of 0oC, tem­
perature reduction was initiated at a rate of 1.5° С per minute 
for 20 minutes followed by a freezing rate of 7°С per minute for 
10 minutes. The cells were then stored in the liquid nitrogen 
vapor phase (-150oC) for 25 to 275 days prior to use. 
Thawing of frozen hepatocytes: 
Hepatocytes were thawed by immersion of a storage vial in a 37°С 
water bath. Immediately after thawing, cells were diluted rapidly 
at 4° С with culture medium and washed twice to remove the cryo-
protectant by centrifugation at 50xg for 5 minutes. 
Cell cultures! 
The culture medium was William s medium E supplemented with 10% 
(v/v) fetal calf serum, 2 mM L-glutamine, 20 mU/ml porcine in­
sulin, 50 nM dexamethasone, 2.5 pg/ml fungizone, 50 ug/ml genta-
mycine, and 100 цд/ті vancomycin. Hepatocytes (stored for 1-2 
years) were seeded at a concentration of 175 χ IO3 cells per 
cm
2
 in polystyrene flasks or dishes coated with extracellular 
121 
biomatrix and maintained in a humidified atmosphere composed of 
95% air and 5% CO2. The medium was renewed 12 hours after cell 
seeding and every 24 hours thereafter. 
Preparation of cell culture substrate: 
Extracellular biomatrix (ECM) from normal adult human liver was 
prepared as described by Rojkind et al. (12) with slight modifi­
cation. After isolation, the extracellular matrix was lyophylized 
and dissolved in 0.1 M acetic acid in a concentration of 200 yg 
protein per ml. This suspension was layered on culture plastic 
(20 pg/cm2) and the acetic acid was evaporized. The culture 
plastic precoated with ECM was washed with Hanks' balanced salt 
solution prior to use. 
Cellular DNA determinations 
Cells were suspended in water and sonicated. After centrifuga-
tion, DNA in supernatant was measured by a fluorometric technique 
as described by Kapuscincki and Skoczylas (13). 
HBV serologic markers; 
Serological HBV markers (HBsAg, anti-HBs, anti-HBc, HBeAg and 
anti-HBe) were determined by commercial enzyme-immunoassays or 
radioimmunoassays (AUSZYME-II, AUSAB, CORAB/CORZYME, АВВОТТ-НВе, 
Abbott laboratories. North Chicago, ILL, USA). 
Immunofluorescent and immunoperoxidase staining of cultured hepa-
tocytes s 
Cells were seeded on glass coverslips precoated with extracellu­
lar matrix. At the indicated times cells were fixed and stained 
with the appropriate antiserum or monoclonal antibody for immuno­
fluorescence and immunoperoxidase analysis. For this study, we 
have used polyclonal rabbit antiserum directed against HBsAg and 
a mouse monoclonal antibody against HBcAg. Antiserum against 
HBsAg was preabsorbed with homogenate of uninfected human liver. 
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The antiserum was clarified by centrifugation. 
Cells were then washed 5 times in phosphate buffered saline (PBS) 
and incubated for 30 min at 37° С with a 1:100 dilution of affini­
ty purified goat anti-rabbit immunoglobulin G or rabbit anti 
mouse immunoglobulin G conjugated to either fluorescein or rhoda-
mine. Cells were washed five times in PBS and coverslips were in­
verted on a drop of 90% (v/v) glycerol-PBS 1 mM EDTA on a micro­
scope slide and viewed with a microscope with epi-illumination. 
For the Immunoperoxidase staining, after incubation with antise­
rum or monoclonal antibody and the washing procedure, cells were 
incubated with goat anti rabbit or rabbit anti mouse immunoglobu­
lin G conjugated to horse radish peroxidase (ENZO, Biochem, New 
York) in PBS containing 1% (w/v) bovine serum albumin. Cells were 
washed in freshly prepared PBS containing 0.1% (v/v) Triton-XlOO 
for 3 min and twice for 3 min in PBS and were developed using a 
freshly prepared PBS mixture containing 0.5 mg/ml diaminobenzidi-
ne tetrachloride (Sigma, St. Louis, U.S.A.) and 0.01% H 20 2 for 20 
min at room temperature. The reaction was then stopped by washing 
with PBS. Cells were counteretalned with 0.25% (w/v) methylgreen 
(Merck, Darmstadt, W.-Germany) in 0.03 M sodium acetate pH 4.8 
for 2 min and washed for 2 min in 0.03 M sodium acetate pH 4.8 
and air dried. After dehydration in aceton-xylene (1:1 v/v) for 1 
min and xylene alone for 3 min, the slides were mounted. 
DNA extraction, gel electrophoresis and molecular hybridization 
with [32p] HBV DNA probe: 
Cultured hepatocytes were homogenized in 4-5 volumes of 0.1 M 
NaCl, 0.05 M Trie HCl pH 7.5, 1 mM EDTA and 3% p-aminosalicylic 
acid. Total nucleic acid was extracted using 2.5 volume of phe-
nol-cresol solution (80% w/v phenol, 11% m-cresol, 9% H2O and 
0.09% 8-hydroxychinolin), followed by chloroform and isoamylalco-
hol (25:1 v/v) at room temperature. DNA was precipitated in 70% 
ethanol at -20°C. The precipitate was then resuspended in 10 mM 
Tris HCl pH 7.5, 1 mM EDTA, and treated with RNAse (Goehringer, 
Mannheim, West-Germany) (final concentration 20 pg/ml) and prote­
inase К (Emerck, Darmstadt, W-Germany) (final concentration 100 
μg/ml) in the presence of sodium dodecyl sulfate (final concen-
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tration 0.5%). The DNA was re-extracted by the chloroform-isoa-
mylalcohol mixture and reprecipitated with ethanol. 
For restriction endonuclease analysis, DNA was digested with 
EcoRl which recognizee one site, and with Hind III, which recog­
nizes no sites within the HBV genome. Purified DNA restriction 
endonucleases were purchased from Boehringer, Mannheim, West-
Germany. Before digestion, DNA was electrophoretically sized to 
make sure that the sample was not degraded. Digestion conditions 
were those recommended by the manufacturer. The final DNA (20 ug 
per sample) was dissolved in buffer (40 mM Tris HCL pH 7.8, 10 mM 
EDTA, 10% glycerol, 0.5% SDS and 0.2% agarose) and incubated at 
45°С for 2 min and applied to the 0.5% agarose gel. 
Electrophoresis was performed with the gel submerged in 40 mM 
Tris HCL pH 7.8, 50 mM sodium acetate, 1 mM EDTA at 30 Volts for 
40 to 48 hrs. DNA was transferred to 0.45 pm nitrocellulose fil­
ter sheets (Schleicher & Schuil, Dassel, W. Germany) according to 
the procedure of Southern (14). The filters were dried, baked in 
a vacuum oven at 80°С for 2 hrs and hybridized with cloned HBV 
DNA labelled with [32P] to a specific activity of 3 to 4 χ 
1θ9 cpm/yg by the method of Rigby et al. (15). 
The HBV DNA probe used for this study was purified HBV DNA of 
3,250 to 3,300 base pair length, isolated by agarose gel electro­
phoresis of glass elution of ECoRl restriction enzyme-treated 
plasmid pAOl-HBV, originally supplied by Dr. J. Summers (The 
Institute for Cancer Research, Fox Chase Cancer Center, 
Philadelphia, Penn. USA) and kindly obtained from Dr. D.A. 
Shafritz (Liver Research Center, Albert Einstein College of 
Medicine, New York, USA). 
Hybridization was carried out at 42° С in a buffer solution con­
taining deionized formamide (50%), 20mM phosphate buffer(pH 6.8), 
Denhardt^s solution (0.02% bovine serum albumin, 0.02% polyvinyl-
pyrolidone, 0.02% ficoll 400), salmon sperm DNA(0.1 mg/ml), 5 mM 
EDTA, 5 χ SSC (1 χ SSC: 0.15 mM NaCl, 0.015 mM Na-citrate) after 
2 hr prehybridization in the absence of HBV DNA probe. The nitro­
cellulose filter was then washed thoroughly under stringent con­
ditions as follows: 2 hours at 420C in the hybridization mixture 
without the probe, 15 min at 42°С in 2 χ SSC'and 0.1% SDS, and 15 
min at 42 0C in 0.2 χ SSC and 0.1% SDS. The filterpaper was dried 
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and autoradiographed with Dupont Cronex Lightning-Plus intensi­
fying screens at -ВСЯС on KODAK XAR-2 film for at least one week. 
In situ cytohybridization of cultured hepatocytes with biotinyla-
ted HBV DNA probe; 
Cultured hepatocytes were fixed in 4% buffered formalin. In situ 
cytohybridization with biotinylated HBV DNA probe was performed 
as described previously (16). 
Electron microscopy; 
Cultured hepatocytes were fixed in situ with 2.0% glutaraldehyde 
containing 0.15 M cacodylate buffer pH 7.4 for 30 minutes at 40C, 
postfixed in a 1% (v/v) osmium tetroxide solution in 0.15 M 
cacodylate buffer pH 7.4 for 60 minutes at 40C, dehydrated by 
ethanol and propylene oxide and embedded in Epon (EMS, Fort 
Washington, NY). Epon was polymerized for 24 hours at 30°С and 
for another 24 hours at 60°C. For these ultrastructural studies, 
cells were seeded in Lux Contur Permanox tissue culture dishes 
(Flow, Irvine, Scotland) at a cell density of 175 χ IO3 per 
cm2. 
Enzyme assays; 
Aspartate amino transferase (ASAT), alanine aminotransferase 
(ALAT), lactate dehydrogenase (LDH), were determined in culture 
medium according to the routine clinical laboratory methods. 
RESULTS 
Extracellular HBV DNA and HBsAg released after infection. 
Despite the negative findings of hepatitis В viral antigens and 
DNA in the hepatocytes in the first 3 days after infection (see 
below), a significant amount of HBV DNA and HBsAg was detected in 
the culture medium after inoculation (figure 1). 
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Figure 1. A representative result of hepatitis В surface an-
tigen (HBsAg) and HBV DNA detection in medium of primary cul­
tures of human hepatocytes after an in vitro infection with 
serum containing hepatitis В virus. 
Infection was carried out two days after cell plating. HBsAg 
was determined by ELISA. HBV DNA was estimated according to 
dot blot technique and hybridization with 3 2P HBV DNA 
probe. Alanine amino transferase (ALAT) and lactate 
dehydrogenase (LDH) were determined according to the routine 
clinical laboratory methods. The results were expressed per 
microgram of cellular DNA. 
Therefore, only a small amount of inoculating virus remained as­
sociated with the hepatocytes and most of the virus did not enter 
the hepatocytes and could still be detected in the culture medium 
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in the subsequent days after inoculation. However, the release of 
HBV DNA and HBsAg in culture medium was increased in the second 
weelt after infection. Although there was some variation in the 
maximal amount and time interval in which the peak value was 
found, the enhanced release of HBV DNA and HBsAg was highly re­
producible for every experiment (total θ experiments). This en­
hanced release of HBV DNA and HBsAg is no proof for viral produc­
tion in infected cells. Nevertheless, this finding could not be 
ascribed to detachment of adsorped viral particles as the result 
of cell death, since the lactate dehydrogenase and alanine amino 
transferase activities in the culture medium as markers of cell 
injury were not elevated in this period (figure 1). The increased 
activities of lactate dehydrogenase and alanine aminotransferase 
in the third week of culture were found in infected cultures as 
well as in control cultures in parallel experiments (data not 
shown). 
Production of viral antigens in infected cells. 
To detect the production of viral antigens in infected cells at 
various intervals after inoculation, we have used immunofluores­
cence and immunoperoxidase staining analysis. In the first two 
days after infection, no cells positive for HBcAg as well as for 
HBsAg were detected. HBcAg was first observed in nucleus of hepa­
tocytes approximately 3 days after infection. On the 7th day, the 
HBcAg was found at a maximal percentage of 0.1% of the cells, 
predominantly in the nucleus (figure 2a-h). The percentage of 
positive cells did not appear to increase after this time. HBsAg 
was first demonstrable also on the 3rd day after infection and 
was predominantly found in the cytoplasm of infected cells (figu­
re 2i-n). The maximal percentage of HBsAg positive cells was sig­
nificantly higher than HBcAg positive hepatocytes. About 5% of 
the hepatocytes was HBsAg positive on the 12th day after infec­
tion. Double staining of hepatocytes for HBsAg and HBcAg indica­
ted that cells positive for HBcAg were also positive for HBsAg. 
However, most of the cells positive for HBsAg were HBcAg negative 
(data not shown). 
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Figure 2. Indirect immunoperoxidase; immunofluorescence and 
in situ cytohybridization of primary cultures of human hepa-
tocytes for the presence of hepatitis В core antigen (HBcAg) 
(panels a-h), hepatitis В surface antigen (HBsAg (panels i-n) 
and hepatitis В virus DNA sequences (panels o-q). 
Cultured hepatocytes are fixed 7 days after infection with 
HBV stained by immunoperoxidase (panels a-c) and by immuno­
fluorescence (panels d-h) for the presence of HBcAg using a 
monoclonal antibody against HBcAg. Fields showing cells with 
predominantly nuclear localization of HBcAg. Panels i-k are 
cultured hepatocytes, fixed 12 days after infection stained 
by immunoperoxidase while panels 1-n are stained by immuno-
flurorescence for the presence of HBsAg. Fields showing cells 
with cytoplasmic localization of HBsAg. 
Detection of HBV DNA sequence in cultured hepatocytes, fixed 
8 days after infection with HBV by the in situ cytohybridiza­
tion technique using a biotinylated HBV DNA probe is shown in 
panels o-q. Fields showing cells with predominantly cytoplas­
mic localization of grains (bar3· 20 pm) N: nucleus. 
Intracellular HBV DNA. 
Using purified HBV DNA probe of 3250 to 3300 base pair length, 
isolated from ECoRl restriction enzyme-treated plasmid PAOj-HBV 
and in situ cytohybridization technique HBV DNA sequences were 
not demonstrable in monolayers of cultured hepatocytes in the 
first two days after infection. On the third day after infection 
and on the subsequent days HBV DNA was detected in 1-5% of the 
cells (figure 20-q), and this percentage of positive cells remai­
ned unchanged during the three week period of the experiment. In 
order to determine whether HBV was replicating by the appearance 
and subsequent amplification of intracellular covalently closed 
circular and single-stranded minus strand replicative DNA inter­
mediates as described by Tuttleman et al(17) for duck hepatitis В 
virus replication, DNA extracted from hepatocytes at various in­
tervals after infection, was also analysed by agarose gel elec­
trophoresis and Southern blot hybridization. As shown in figure 
3, there were HBV DNA sequences of 3.2 kilobase pair length in 
every DNA preparation of hepatocytes except in DNA preparations 
of hepatocytes before and in the first two days after infection. 
The amount of HBV DNA sequences appeared to be increased up to 12 
days after infection. This finding is in agreement with the find­
ing of in situ cytohybridization analysis. Furthermore, a small 
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quantity of replicative HBV DNA intermediates was observed in the 
first week after infection. 
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Figure 3. Southern blot analysis of intracellular HBV DNA on 
a 0.5% agarose gel. 
32p-HBV DNA probe was hybridized to various DNA samples 
extracted from primary cultures of human hepatocytes. C: con­
trol uninfected cultured hepatocytes. 1,4,6,8,10,12,14,16 and 
18 are DNA extracted from cultured hepatocytes 1,4,6,8,10,12-
14,16 and 18 days respectively after an in vitro infection 
with HBV. Numbers to the left of the figure refer to DNA size 
in kilobases. 
Electron microscopy. 
To study the morphogenesis of viral replication in this experi­
mental infection, electron microscopic studies were performed on 
the infected hepatocytes every 2 days for 3 weeks. In the first 
four days after infection, despite the intensive and careful exa-
Figure 4. Transmission electronmicrographs of primary cultu-
res of human hepatocytes twelve days after an in vitro infec­
tion with hepatitis В virus (horizontal bar= 200 nm). Panels 
a and b show 42 nm virus-like particles located in vesicular 
structures found in cytoplasm of infected hepatocytes. These 
particles seemed to be assembled and released by protrution 
of core like structures into the ER (endoplasmic reticulum) 
cisternae with invagination of ER membranes that coated the 
core particles (c-i). M: mitochondrion MV= microvillus N= 
nucleus Arrows: virus-like particles. 
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mination, no virus-like particles were observed in these hepato­
cytes. However, one to two weeks after infection, 42 nm virus 
like particles located in vesicular structures were found in the 
cytoplasm of infected hepatocytes (figure 4a,b). These particles 
were not seen in uninfected hepatocytes in parallel experiments. 
As shown in figure 4c-i, these particles seemed to be assembled 
and released by protrusion of core like structures into the ER 
(endoplasmic reticulum) cisternae with invagination of ER membra­
nes that coated the core particles. Budding through the cell mem­
brane from microvilli was not observed in this experimental in-
nection. 
DISCDSSIOH. 
Although the recognition, that hepatoma cell lines, such as 
PLC/PRF/5 Alexander cell line (18), produce hepatitis В surface 
antigen in the absence of any detectable virus particles, has 
provided an experimental system which has improved our understan­
ding of the pathobiology of hepatitis В virus, inoculation of 
many cell lines including PLC/PRF/5 and HEP G2 cell lines and 
primary cultures of non-human hepatocytes with hepatitis В virus 
has not resulted in production of Dane particles or HBcAg. Since 
a specific viral receptor molecule may be important for absorp­
tion followed by penetration of viral particles into the cells as 
described for many other viruses (19), the failure of these in 
vitro infections could be due to the lack of a specific "HBV re­
ceptor" on the plasma membranes of these cell lines and non-human 
hepatocytes. Furthermore, the absence of an appropriate intracel­
lular environment (highly differentiated liver functions) for vi­
ral replication and development could also be responsible for the 
limited success. It seems, therefore, very suitable to use prima­
ry cultures of normal human hepatocytes under "optimal" condi­
tions for the in vitro propagation of HBV, since HBV replicates 
primarily in human hepatocytes in vivo and can establish chronic 
infection. Attempts to infect primary human hepatocyte cultures 
have been reported previously (20-22). Although intracellular vi­
rus specific proteins were detected after inoculation with HBV, 
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and extracellular viral particles were found in the culture medi­
um, there was no substantial evidence for the production of viral 
antigens and the presence of viral replication in these hepatocy-
tes. The limited success of in vitro infection of HBV in human 
hepatocytes in the past could be due to the lack of appropriate 
methods for culturing human hepatocytes allowing viral replicati­
on. Furthermore, the limited availability of viable human hepato­
cytes did not provide the possibility for intensive investigation 
of in vitro infection with HBV. In this paper we demonstrate a 
reproducible and efficient system for infecting cells in vitro 
with hepatitis В virus after establishing the "optimal" culturing 
conditions and developing a cryopreservation technique for stora­
ge of normal human hepatocytes. By using cryopreserved hepatocy­
tes and primary cultures on extracellular matrix, well-scheduled 
reproducible and large scale experiments with the neccessary ca­
reful preparations have been performed. 
Via immunofluorescence and immunoperoxidase analysis to demon­
strate HBsAg and HBcAg production in infected hepatocytes, we we­
re unable to detect positive cells in the first two days after 
inoculation. However, on the third day few cells became HBcAg and 
HBsAg positive and the number of positive cells was increased in 
the subsequent days. The HBcAg was observed predominantly in the 
nucleus of the cells, whereas HBsAg was found almost exclusively 
in the cytoplasm of the hepatocytes. This series of events sug­
gest that viral replication and production of viral antigens are 
taking place in these primary cultures of human hepatocytes. The­
se findings could not be explained by contamination of hepatocy­
tes with HBV from the inoculum. The relatively low percentage of 
HBcAg positive cells as compared to the percentage of HBsAg posi­
tive hepatocytes could be due to a low production of HBcAg and/or 
the result of coating of core particles by HBsAg in the formation 
of virions. Alternatively the sensitivity of HBcAg detection 
using a monoclonal antibody for the imraunoetaining assays could 
be lower than for HBsAg detection using polyclonal rabbit antise­
rum. 
In these experiments, it is interesting to note that viral anti­
gens could be detected in hepatocytes only when in vitro infec­
tion of hepatocytes was performed in the presence of blood obtai-
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ned from healthy HBsAg negative and anti-HBc negative subjects 
(data not shown). Therefore, (a) factor(s) in human blood could 
have been required for early events in viral entry into cells. 
The maximal percentage of positive cells for viral antigens and 
for HBV DNA is approximately the same for every experiment. Since 
this percentage remained unchanged, when cells were exposed to 
virus one to seven days after plating, the susceptibility of he-
patocyte cultures to infection was probably also the same in this 
period. Furthermore, multiplicity of infection by increasing the 
amount of inoculum did not lead to a substantial increase of in­
fected cells as also shown in in vitro infection of duck hepati­
tis В virus in primary cultures of duck hepatocytes (17). Al­
though the isolation and the cryopreservation procedures could 
have destroyed the capacity of hepatocytes for infection, and 
surface antigen particles in the inoculating virus preparation 
could have competed with the virus for cell surface receptors, 
the finding of limited number of cells positive for viral anti­
gens and HBV DNA in in vitro infection is in concordance with 
biopsy findings of patients with HBV infection. In liver biopsies 
of HBeAg positive patients, viral antigens and HBV DNA were not 
detected in every cell. In contrast to the finding of in vitro 
infection of duck hepatitis В virus (17) we were only able to de­
monstrate the presence of small amount of HBV DNA intermediates 
in monolayer cultures of human hepatocytes in the first week af­
ter infection with HBV. These findings are in agreement with the 
results of immunostaining analysis and electron microscopy. This 
in vitro infection of primary cultures of cryopreserved human he­
patocytes with hepatitis В virus provides therefore a suitable 
and reproducible system for studying the mechanism of HBV infec­
tion. Detailed studies on the attachment of HBV to the hepatocyte 
plasma membrane, the entry into the cell, viral replication, ma­
turation as well as studies on the molecular and cellular mecha­
nisms of hepatocellular necrosis due to hepatitis В virus infec­
tion could be performed using this in vitro model. However, fur­
ther improvement of culture system is needed to increase the num­
ber of infected cells and for active viral replication. 
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SAMENVATTING EN CONCLUSIES 
In hoofdstuk I worden de algemene eigenschappen van het hepatitis 
B-virus (HBV) besproken. Het HBV is een DNA-virus dat zich na 
infectie via bloed, bloedproducten en bepaalde andere lichaams-
vochten in de levercellen kan vermenigvuldigen. Het virion is onge-
veer 42 nm groot. De belangrijkste bouwstenen ervan zijn een man-
teleiwit (HBsAg), een kerneiwit (HBcAg) en incompleet dubbelstrengs 
DNA. Het kan een breed scala van ziektebeelden veroorzaken. Deze 
kunnen zich uiten in de vorm van geelzucht (acute hepatitis) die 
slechts zelden fulminant is. B13 veel patiënten verdwijnt het virus 
(en daarmee de ziekteverschijnselen) na verloop van tijd door toe-
doen van het immuunsysteem. In ongeveer 10% van de gevallen echter 
is de immuunafweer onvoldoende en treedt een chronische hepatitis 
op (hetzij klinisch, hetzij subklinisch). Bij langdurig lijden aan 
chronische hepatitis kan levercirrhose en/of leverkanker ontstaan. 
Hepatitis В komt in de westerse wereld relatief weinig voor. Over 
de gehele wereld zijn er echter ongeveer 200 miljoen dragers van 
het virus. De met hepatitis В geassocieerde leverkanker is de meest 
voorkomende vorm van kanker in sommige Aziatische landen, waar een 
hoge incidentie van HBV-mfectie wordt gevonden. 
Er wordt zeer veel onderzoek verricht aan de biologie van het virus 
en er zijn de laatste jaren ook grote vorderingen gemaakt. Veel 
facetten zijn echter nog onvoldoende opgehelderd. Eén van de be-
langrijkste oorzaken hiervoor is het feit dat het HBV zeer gast-
heerspecifiek is, hetgeen wil zeggen dat het ziektebeeld niet bij 
andere organismen voorkomt (afgezien van chimpansees). Bovendien is 
het tot nu toe niet mogelijk gebleken het virus in vitro te kweken. 
Wel kennen enkele knaagdier- en eendesoorten verwante virusinfec-
ties die evenwel ieder hun specifieke eigenschappen hebben, waar-
door deze virussen niet als model kunnen dienen voor het bestuderen 
van HBV-infectie. Daarom hebben wij in ons laboratorium onderzocht 
of het mogelijk is om humane levercellen te isoleren, in kweek te 
brengen en in vitro te infecteren met HBV. Op deze manier kan men 
de interactie tussen het virus en zijn specifieke gastheercellen 
rechtstreeks bestuderen en kunnen wellicht bepaalde hiaten in de 
kennis van de biologie van het virus opgehelderd worden. Ook zou 
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bijvoorbeeld de invloed van antivirale middelen en antistoffen na 
vaccinatie op deze wijze veel eenvoudiger bestudeerd kunnen 
worden. 
In de hoofdstukken II en III wordt beschreven hoe wi] de isolatie 
en kweekomstandigheden van humane levercellen hebben uitgevoerd en 
verbeterd. Het blijkt mogelijk te zijn om de geïsoleerde hepato-
cyten zodanig in te vriezen dat ze nadien op ieder gewenst moment 
m kweek gebracht kunnen worden, waardoor men voor experimenten 
niet meer afhankelijk is van het op onregelmatige tijden beschik-
bare verse leverweefsel. Bij het onderzoek is ook gebleken dat uit 
lever geëxtraheerd steunweefsel (extracellulaire matrix) de levens-
duur en de specifieke functies van de gekweekte hepatocyten gunstig 
beïnvloedt. 
In de hoofdstukken IV, V en VI wordt beschreven hoe het mogelijk is 
in serum, in leverweefsel en in levercellijnen viraal DNA aan te 
tonen door middel van moleculaire hybridisatietechnieken (deze wor-
den in hoofdstuk IV in detail uiteengezet). Met de Southern blot-
techniek kan men bepalen in welke vorm het virale DNA aanwezig is. 
HBV-DNA kan in vrije vorm in de hepatocyten aanwezig zijn, hetgeen 
wijst op een actieve virusreplicatie. Het virus-DNA kan bovendien 
integreren in het gastheer-DNA, hetgeen verband lijkt te houden met 
de ontwikkeling van een levertumor. Met behulp van de in situ-hybri-
disdtietechniek kan men vaststellen in hoeveel en in welke cellen 
van een weefselcoupe of een celkweekpreparaat het virale DNA aan-
wezig is. 
Hoofdstuk VII is een compilatie van de vorige hoofdstukken. In dit 
hoofdstuk wordt beschreven hoe wij met behulp van de ontwikkelde 
detectiemethoden konden aantonen dat de onder geoptimaliseerde 
omstandigheden gekweekte humane hepatocyten met HBV geïnfecteerd 
kunnen worden. Gekweekte humane hepatocyten werden met infectieus 
serum geïncubeerd en de effecten daarvan werden op verschillende 
tijdstippen hierna bekeken. Een aantal dagen na infectie bleken 
HBsAg en HBcAg in de cellen aanwezig te zijn, evenals het virale 
DNA; dit laatste werd aangetoond met behulp van in situ hybridi-
satie en Southern blot-analyse. Zowel HBsAg als viraal DNA bleken 
rond de tiende dag na infectie in de grootste hoeveelheden uit de 
hepatocyten vrij te komen. Ook op electronen microscopisch niveau 
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uit de hepatocyten vrij te komen. Ook op electronen-microscopisch 
niveau werden na infectie virusachtige deeltjes in de hepatocyten 
gevonden. Op grond van deze resultaten kan men concluderen dat in 
dit modelsysteem humane hepatocyten met HBV geïnfecteerd kunnen 
worden. Desalniettemin is onderzoek naar de optimale kweekcondities 
voor hepatitis В virusreplicatie noodzakelijk. 
141 
SUMMARY AND CONCLUSIONS 
In chapter I the general characteristics of the hepatitis В virus 
(HBV) are discussed. The HBV is a DNA virus that can multiply in 
liver cells (hepatocytes) after infection through blood or blood 
products and certain other body fluids. The diameter of the virion 
is about 42 nm. Its main components are a surface protein (HbsAg), 
a core protein (HBcAg) and an incomplete double stranded DNA. HBV 
can cause a wide variety of clinical manifestations. These can 
become manifest as an acute hepatitis in the presence of jaundice, 
which is, however, seldom fatal. In many patients the virus as well 
as the disease disappear after some time through the immune system. 
In about 10% of the patients, however, the immune reaction is 
insufficient to clear the virus and a chronic hepatitis develops 
(either clinical or subclinical). Prolonged chronic hepatitis can 
lead to the development of liver cirrhosis and/or liver cancer. 
Hepatitis В is not very common in the West. Worldwide, however, 
about 200 million people are HBV carriers. Liver cancer, which is 
associated with HBV infection is the most common form of cancer in 
some Asian countries with a high incidence of HBV infection. 
Much research is being conducted on the biology of the virus. Not­
withstanding the fact that much progress has been made during the 
last few years, many aspects of HBV infection still have to be 
clarified. However, because of the host specificity of this virus, 
animal models for the study of HBV infection are not available 
(with the exception of chimpanzees). Furthermore, hepatitis B-like 
viruses, as found in certain rodent and duck species, are also not 
suitable for the study of the typical aspects of the human hepati­
tis virus, owing to their own specific characteristics. We there­
fore explored the possibility of isolating and culturing human 
liver cells and infecting them in vitro with HBV in our laboratory. 
The interaction between the virus and its specific host cells can 
thus be studied directly and some gaps in the knowledge of the 
biology of the virus may be elucidated. Likewise, the effects of 
drugs and antibodies after vaccination on a HBV infection could be 
examined more easily. 
The isolation and culturing conditions of human hepatocytes are 
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described in chapter II and chapter III. It is possible to cryopre-
serve the isolated hepatocytes; they can be thawed and seeded 
afterwards at any time, thus avoiding having to be dependent on 
irregularly available liver tissue for experiments. We were also 
able to show that tissue, extracted from the liver (extracellular 
matrix), has a positive effect on the survival and specific 
functions of the cultured hepatocytes. 
Chapters IV, V and VI describe how viral DNA can be detected in 
serum, liver tissue and liver cell lines, by using molecular hybri­
dization techniques (which are explained in detail in chapter IV). 
With the Southern blot technique the form in which the viral DNA is 
present can be determined. HBV DNA can be present in hepatocytes in 
an extrachromosomal form, indicating viral replication, or in a 
chromosomal form. In this latter form, HBV DNA is found in the host 
DNA in an integrated form. Integration of viral DNA is thought to 
be correlated with the development of liver cancer. Using the in 
situ hybridization technique it can be demonstrated in how many and 
in which cells of a tissue section or tissue culture preparation 
viral DNA is present. 
Chapter VII is a compilation of the previous chapters. It describes 
how human hepatocytes can be infected with hepatitis В virus, using 
the optimized cultunng conditions and the developed techniques for 
HBV detection. A few days after infection HBsAg and HBcAg, as well 
as the viral DNA, proved to be detectable in the cells. At about 
the tenth day after infection the hepatocytes appeared to release 
maximal amounts of HBsAg as well as viral DNA. In addition, ultra-
structural studies demonstrated virus-like particles in the hepato­
cytes after infection. On the basis of these results it can be con­
cluded that human hepatocytes in primary cell lines can be infected 
with the hepatitis В virus. However, further improvement of the 
culture conditions is needed to increase the number of infected 
cells and for the enhancement of active HBV replication. 
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VII 
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ven. Meis JFGM et al., Am J Trop Med Hyg 37:506, 1987; Guerin-
Marchand С et al., Nature 329:164, 1987. 
VIII 
De homologie tussen het int-1 proto-oncogen van de muis en het 
wingless segment polanteitsgen van Drosophila melanogaster laat 
zien dat differentiatie en tumorontwikkeling nauw verbonden biolo­
gische processen zijn. Rijsewijk F et al.. Cell 50:649, 1987; 
Cabrera CV et al., Cell 50:659, 1987. 
IX 
Doordat de polymerase chain reaction (PCR) gebruik maakt van één 
van de voor DNA unieke eigenschappen kan er meer diagnostisch on-
derzoek gedaan worden aan zeer kleine hoeveelheden DNA. Chehab FF 
et al.. Nature 329:293, 1987; Saiki RK et al., Science 230:1350, 
1985. 
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Hoe dieper men op de moleculaire biologie van het hepatitis B-virus 
ingaat, hoe meer men gefascineerd raakt door de efficiëntie waarmee 
het virus van z'n DNA gebruik maakt. Ganem D, Varmus H, Ann Rev 
Blechern 56:651, 1987. 
XI 
Het begrip hepatitis non-Α, non-B is een taalkundig gedrocht waar 
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XII 
Het bezit van geavanceerde apparatuur is geen garantie voor de kwa­
liteit van het onderzoek. 
XIII 
Malariasporozoïeten verkregen uit zwaar geïnfecteerde muggen zijn 
minder infectieus voor hepatocyten in vitro dan parasieten af-
komstig van licht geïnfecteerde muggen. 
XIV 
Het gebrek aan organisatie wordt altijd afgewenteld op degenen die 
er onder de omstandigheden het beste van willen maken. 
XV 
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XVI 
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